laca 2017 final programlaca2017.kenes.com/documents/laca 2017 final program.pdf · 5th latin...

5th Latin AmericanCongress on

Cancun, Mexico, 26-29 November 2017

5tH LAtIN

AM

ERICAN CoNgREss oN AutoIMMuNIty

Final Program

Rue François-Versonnex 71207 Geneva, SwitzerlandT: +41 22 908 0488F: +41 22 906 9140 laca.kenes.com

2

Table of Contents

Congress Information Program at a Glance 3

Venue Map 7

Welcome Message 8

Committees 9

General Information 10

Information for Presenters 12

Recognition, Acknowledgements & Industry SupportAcknowledgements 14

Exhibition Map 15

Exhibitor Company Profiles 16

Scientific ProgramSunday, 26 November 19

Monday, 27 November 23

Tuesday, 28 November 33

Wednesday, 29 November 43

Poster Session 1: Monday, 27 November 47

Poster Session 2: Tuesday, 28 November 57

Index of Authors 67

3

5th Latin American Congress on Autoimmunity

Program at a Glance

Plenary Session in English, without translation

Networking event Free Communications

Parallel Session in English, without translation

Parallel Session in Spanish, without translation

Course in Spanish, without translation

Sunday, 26 November Grand Coral 1

13:00-15:00 Clinical Immunology Course (Spanish)Part 1: The interaction between external and internal factors for the development of autoimmune diseases Chairs: Juan Manuel Anaya, Luis Javier Jara Quezada• Yehuda Shoenfeld, Israel : Opening Words• Carolina Ramirez Santana, Colombia: Zika virus infection and autoimmune neurological syndromes • Olga Vera Lastra, Mexico: Chikungunya virus infection: Latin American experience • Luis Javier Jara Quezada, Mexico: Immune neuro-endocrine interactions and autoimmune

rheumatic diseases• JuanManuelAnaya, Colombia: The interaction between genes and autoimmune diseases

15:00-15:30 Coffee Break

15:30-17:30 Clinical Immunology Course (Spanish)Part 2: Modulation of the immune response Chairs: Claudio Galarza-Maldonado, Roger A Levy• Morton Scheinberg, Brazil: Belimumab and other anti baffs • Claudio Galarza-Maldonado, Ecuador: Rituximab and other anti-B cell antibodies - Latin American

experience • LuisE.Andrade, Brazil: Pre-autoimmunity: a unique opportunity for understanding and modulating

autoimmunity

17:30-20:00 Opening Ceremony followed by Welcome Reception

4

Monday, 27 NovemberGrand Coral 1 Grand Coral 2

8:00-10:00 PlenarySession1:AntiphospholipidSyndromeChairs: Roger Levy, Yaniv Sherer• MaryCarmenAmigo, Mexico: The heart and APS• Ricard Cervera, Spain: Renal involvement in the

antiphospholipid syndrome• Roger Levy, Brazil: New and upcoming treatments

for APS • Thierry Dervieux, USA: Complement activation in

relation to Lupus and antiphospholipid antibodies: Insights from the clinical laboratory

• Edward Kane, USA: Phosphatidylcholine (PC) and the membrane dynamics

10:00-10:40 Coffee Break, Exhibition & Poster Viewing

10:40-12:40 ParallelSession1:SystemicAutoimmuneDiseasesChairs: Luc Mouthon, Enrique R. Soriano• Luc Mouthon, France: Treatment of ANCA-associat-

ed vasculitis• Enrique Roberto Soriano, Argentina: Renal involve-

ment of ANCA vasculitis• Ernesto Cairoli, Uruguay: Usefulness of cardiac

magnetic resonance in the cardiovascular evaluation of systemic sclerosis

• Gabriela Medina, Mexico: Metabolic syndrome, autoimmunity and autoimmune rheumatic diseases

• Bernardo Rodriguez Iturbe, Venezuela: Renal, vascular and central nervous system mechanisms of hypertension induced by immunity

• Dimitrios Karussis, Israel: Multiple sclerosis – a clas-sical autoimmune disease

ParallelSession2:AutoantibodyUpdates Chairs: Luis EC Andrade, Ricard Cervera• LuisECAndrade, Brazil: Why autoanti-

body standardization is so critical for the diagnosis of autoimmune diseases

• AlejandraBabini, Argentina: Could the im-mune system be reset in early autoimmune diseases?

• JoseAlfredoGomez-Puerta, Colombia: Differences among ACPA positive and ACPA negative Rheumatoid arthritis patients

• Monica Vazquez del Mercado, Mexico: DFS interpretation

• Veronica Vilela, Brazil: New autoantibodies in dermatomyositis: serological specificities and phenotype correlations

• 2OralPresenations

12:40-13:50 Lunch Break, Exhibition & Poster Viewing

13:50-15:50 Free Communications 1 (English)

Chairs: Morton Scheinberg, Brazil Guillermo Pons-Estel, Argentina Marta Alarcon Riquelme, Spain

Free Communications 2: Barcelona ClínicAutoimmunity-Alumni(BilingualSession) Chairs: Ricard Cervera, Spain Manuel Ugarte-Gil, Peru Ernesto Cairoli, Uruguay


16:30-18:00 PlenarySession2:Genomics,AutoimmunityandAutoimmuneDiseasesinLatinAmericaChairs: Julio Granados-Arriola, Marta Alarcón-Riquelme• Juan-ManuelAnaya, Colombia: Commonalities

among autoimmune diseases• MartaAlarconRiquelme, Spain: Autoimmune

disease stratification• JulioGranados-Arriola, Mexico: HLA and disease• Patricia Kane, USA: Genetics and epigenetics in

Autoimmunity

5


Tuesday, 28 NovemberGrand Coral 1 Grand Coral 2

8:00-10:00 PlenarySession3:AutoimmunityinLatinAmerica Chairs: Luis J Jara, Mario Cardiel• Mario Cardiel, Mexico: Practical aspects in rheuma-

toid arthritis treatment in Latin America• LuisJavierJara, Mexico: Autoimmunity in Latin

America: scientific productivity in this century • PatriciaAbumohor, Chile: Clinical manifestations of

gluten related disorders• Carolina Ramirez-Santana, Colombia: The Autoim-

mune Ecology• ClaudioGalarza-Maldonado, Ecuador: Antiphospho-

lipid syndrome and pregnancy: 20 years of experience in Ecuador


10:40-12:40 ParallelSession3:InfectioninAutoimmunity Chairs: Luis R. Espinosa, Claudia Mendoza• LuisR.Espinoza, USA: HIV - Overview and how it

affects the natural history, course, and approach to therapy of autoimmune disorders

• Claudia Mendoza-Pinto, Mexico: Human papillomavi-rus infection in systemic lupus erythematosus

• Ricard Cervera,Spain: The role of infectious diseases in the catastrophic antiphospholipid syndrome

• Olga Vera-Lastra, Mexico: Is Chikungunya virus infec-tion a risk factor for developing rheumatoid arthritis?

• Jorge Oscar Garcia Mendez, Mexico: The paradoxi-cal effect of infectious diseases on autoimmunity: main difference between rich and poor countries

• Carlos Vasconcelos, Portugal: Infection in autoim-mune patients; a center experience

Parallel Session 4: Systemic Lupus Erythematosus Chairs: Manuel Ugarte-Gil, Guillermo Pons-Estel• ManuelUgarte-Gil, Peru: Flares in SLE.

Predictors and consequence• Guillermo Pons-Estel, Argentina: Anti-

malarials old drug, new indications for SLE

• Enrique R. Soriano, Argentina: Epidemi-ology of Lupus in Latin America

• JoseAlfredoGomez-Puerta, Colombia: Urinary biomarkers in SLE

• JorgeAlcocerVarela, Mexico: Par-ticipation of IL-2 in the pathogenesis of Systemic Lupus Erythematosus

• 2OralPresenations

12:40-13:50 Lunch Break, Exhibition & Poster Viewing

13:50-15:50 Free Communications 3 (English)

Chairs: Christopher Edwards, United Kingdom Simone Appenzeller, Brazil

Free Communications 4 (Bilingual Session) Chairs: Bernardo Rodriguez Iturbe, Venezuela Chaim Putterman, USA


16:30-18:00 PlenarySession4:TheASIASyndrome Chairs: Olga Vera-Lastra, Manuel Martinez-Lavin• Yehuda Shoenfeld, Israel: Autoimmune/inflammatory

syndrome induced by adjuvants - An update• Olga Vera-Lastra, Mexico: Autoimmune/Inflammatory

syndrome induced by mineral oil. A health problem in Latin America

• Manuel Martinez-Lavin, Mexico: HPV vaccine and fibromyalgia

• Dimitrios Karussis, Israel: Vaccines and autoimmunity in CNS

6

GRAND CORAL FOYER

GRAND CORAL 1

GRAND CORAL 2EXHIBITION, POSTERS

HALL A

HALL B

REGISTRATION

Wednesday, 29 NovemberGrand Coral 1

8:00-10:00 Plenary Session 5: The Environment in Autoimmunity Chairs: Eric Gershwin, Mario García Carrasco• Mario García Carrasco, Mexico: Vitamin D and Autoimmune diseases • Eric Gershwin, USA: Sex, Genetics and the Environment• Laurel Gershwin, USA: Emerging Autoimmunity in Domestic Animals • Monica Vazquez del Mercado, Mexico: Obesity, autoimmunity, and autoimmune diseases• Kishore Malyavantham, USA: Improved ANA screening algorithm using a novel DFS70 Knock Out

HEp-2 IIF

10:00-10:40 Coffee Break & Exhibition

10:40-12:40 Plenary Session 6: Advances in Autoimmune Disease TherapyChairs: Morton Scheinberg, Chaim Putterman• Morton Scheinberg, Brazil: The future landscape of biosimilars in rheumatology • Chaim Putterman, USA: Targeting macrophages for the treatment of lupus nephritis (animal model/

translational)• Simone Appenzeller, Brazil: Role of antibodies and cytokines in CNS manifestations in SLE• Christopher Edwards, UK: Dose tapering of biological therapies: safe or not? • Roger A Levy, Brazil: Synthetic and biologic therapy during pregnancy and lactation in SLE• Juan C. Aguillon, Chile: The present of dendritic cells-based therapy for autoimmunity

7


Venue Map

GRAND CORAL FOYER

GRAND CORAL 1

GRAND CORAL 2EXHIBITION, POSTERS

HALL A

HALL B

REGISTRATION

8

Welcome Message

Dear Colleagues,

We gather again for a cutting edge Congress on the science of Autoimmunity.

Several international opinion leaders have joined a number of distinguished Latin American autoimmunologists, to create an environment of dynamic scientific exchange about recent progress in the field. With this, we brought together the most prolific investigators in Autoimmunity to present their recent work and debate with their peers and the audience.

LACA 2017 applies a multidisciplinary approach, focusing on all aspects of the challenge of understanding and offering a better care to people with autoimmune disorders.

The scientific program includes updates on novel therapies in autoimmune diseases such as SLE, IBD and neurological diseases, alongside novel themes like Chikungunya in the region of the Americas, the Zika virus and Autoimmunity, and many more.

We are excited to welcome you in beautiful Cancun for this captivating Congress.

Sincerely yours,

Prof. Luis Javier Jara Quezada, MD, MaMCR, MaACRLACA 2017 Congress Chairman

Prof. Yehuda Shoenfeld, MD, FRCP, MaACRLACA 2017 Honorary Chairman

9


Committees

ChairpersonLuis Javier Jara Quazada, Mexico

Honorary ChairsYehuda Shoenfeld, Israel

Ricard Cervera, Spain

Co-ChairpersonsRoger Levy, Brazil

Claudio Galarza, Ecuador

Juan-Manuel Anaya, Colombia

Scientific CommitteePatricia Abumohor, Chile

Alejandra Babini, Argentina

Local Advisory CommitteeJorge Alcocer Varela, Mexico

Mary Carmen Amigo, Mexico

Mario Cardiel, Mexico

Mario Garcia Carrasco, Mexico

Jorge Oscar García Méndez, Mexico

Julio Granados Arriola, Mexico

Manuel Martinez-Lavin, Mexico

Monica Vazquez del Mercado, Mexico

Olga Vera-Lastra, Mexico

International Advisory CommitteeMarta Alarcon Riquelme, Spain

Luis E.C. Andrade, Brazil

Simone Appenzeller, Brazil

Ernesto Cairoli, Uruguay

Christopher Edwards, UK

Luis R. Espinoza, USA

Eric Gershwin, USA

José-Alfredo Gómez-Puerta, Colombia

Luc Mouthon, France

Guillermo Pons-Estel, Argentina

Chaim Putterman, USA

Bernardo Rodriguez Iturbe, Venezuela

Morton Scheinberg, Brazil

Manuel Ugarte-Gil, Peru

Verônica Vilela, Brazil

10

General Information

Congress VenueGrand Fiesta Americana Coral Beach CancunBlvd. Kukulcán km. 9.5 Zona Hotelera77500CancúnQuintana Roo, MéxicoPhone: +52 (998) 881 3200

RegistrationThe Registration Desk will be open at the Congress venue as follows:

Date Registration Hours

Sunday, 26 November 12:00 - 19:30

Monday, 27 November 07:30 - 18:00

Tuesday, 28 November 07:30 - 18:00

Wednesday, 29 November 07:30 - 13:00

Participants BadgeUpon registration, you will receive your name badge. You are kindly requested to wear your badge during all Congress sessions and events.

WIFI Free WIFI will be available at the congress. Please be aware that public WIFI capacity is always limited and therefore limited to email and web browsing activity.

RefreshmentsCoffee and lunch will be served in the Exhibition hall at the times indicated in the Scientific Program.

Exhibition Opening TimesDate Exhibition Hours

Sunday, 26 November 18:00 - end of Welcome reception

Monday, 27 November 09:30 - 17:00

Tuesday, 28 November 09:30 - 17:00

Wednesday, 29 November 09:30 - 13:00

Mobile PhonesMobile phones must be muted during all sessions.

11


Safety & SecurityPlease do not leave any bags or suitcases unattended at any time, whether inside or outside session halls.

Liability & InsuranceThe Congress Secretariat and Organizers cannot accept liability for personal accidents or loss of or damage to private property of participants. Participants are advised not to leave their personal belongings unattended in session halls and throughout the Congress venue.

Smoking PolicySmoking is prohibited throughout the Congress venue. Please be considerate of the rules of the venue and your fellow participants.

Emergency Telephone NumbersFire department, Police and Ambulance services are available via telephone number 066.

Congress Secretariat

Website: www.kenes.com

12

Information for Presenters

Please check the program in case of last minute scheduling changes.

Oral Presentations Data presentation:Speakers and oral presenters are requested to upload PowerPoint slide presentations at the AV station at the back of your session hall at least 30 minutes prior to your session. There will be a technician available to assist you during Congress hours.

Please note that the Congress computers in the session halls are being supplied with Office 2010 (at least).

Please note the native projection ratio in the session halls is 16:9 – it is recommended to prepare your PowerPoint Presentation accordingly.

Note- there is one computer for uploading your PowerPoint Presentation in each hall, therefore it is advised to do so as soon as you arrive.

Although not recommended, you may supply your own laptop computer. In such a case please confirm that it has a suitable VGA or HDMI socket for external signal. Please come to check it as soon as you arrive in the session hall where your presentation is taking place during the coffee or lunch break prior to your session.

Important Note For Macintosh UsersIn order to use MAC presentations on a PC compatible computer please note that you need to prepare it according to the instructions below, before bringing it to the uploading station in the session hall:

1. Use a common font, such as Arial, Times New Roman, Verdana etc. (special fonts might be changed to a default font on a PowerPoint based PC).

2. Insert pictures as JPG files (and not TIF, PNG or PICT - these images will not be visible on a PowerPoint based PC ).

Alternatively you may use your own Macintosh laptop computer. In such a case please confirm you provide it with a VGA or HDMI adaptor for external signal and come to test it as soon as you arrive in the session hall where your Presentation is taking place during the coffee or lunch break prior to your session.

At the Session Hall

• Assembleinyoursessionroomatleast10minutesbeforethebeginningofthesession.

• Pleasecheckthefinalprogramtoconfirmthedate,time,roomandorderofyourpresentation.

• Ensurethatyousitnearthefrontoftheroomwitheasyaccesstotherighthandsideofthestage.

• Ensurethatyoukeeptothetimeallocatedtoyou,asitwillcausedisruptiontosessionsifyourunoveryour allotted time.

• Ifthereareanychangesorcorrectionsrequiredtothepresentationdetails,pleaseletthetechnicianknowas soon as possible.

13


Poster Presentations

Please see the scientific program for the board number on which you should display your poster.

Posters should be hung on the day of scheduled presentation and must be removed by the end of day.

There are 2 poster sessions as below:

Poster Session 1: Monday, 27 November, 2017

Poster Session 2: Tuesday, 28 November, 2017

Presenters are able to set up their posters from 07:30

Posters should be removed after 18:00 at the conclusion of the main session.

The organisers are not responsible for any posters that have not been removed by the end of the sessions on the day in which they have been scheduled.

Poster AreaAll poster boards will be situated in the exhibition hall.

14

Acknowledgements

The Organizing Committee of the 5th Latin American Congress on Autoimmunity would like to express its gratitude and acknowledge the following companies for their generous support of the Congress:

Supporters

Exhibitors

15


Exhibition Map

03

02

06

07

04

POSTER AREA

08

05

Exhibitor Booth no.

HUMAN Diagnostics Worldwide 02

Inova 03

BodyBio Inc 04

Exagen 05

MEDIPAN GMBH 06

GRIFOLS 07

Trinity Biotech plc 08

16

Exhibitor Company Profiles

BodyBio Inc 45 Reese RdMillville08332USABooth #: 04http://bodybio.comBodyBio Inc. was formed in 1998 to support the needs of physicians to address their patients’ aberrant biochemistry with evidence based biomedical intervention. BodyBio’s focus has been on the research of targeted bio-metabolic nutritional support for chronic, acute and metabolic illness. As an evidence based research company we have provided diagnostic services and nutritional support to thousands of practitio-ners for their patients. Based on this research, BodyBio was one of the first to introduce innovative products for physicians such as E-Lyte Balanced Electrolyte, BodyBio Liquid Trace Minerals, BodyBio Balance oil (4:1 Omega 6 : Omega 3) and BodyBio Phosphatidylcholine complex.

Exagen 1261 Liberty Way, Suite CVista, CA92081USABooth #: 05http://www.exagen.com/Exagen Diagnostics, Inc. is a patient focused, discovery driven laboratory serving the specialized needs of the rheumatology community. They are committed to providing physicians with accurate and clinically actionable diagnostic, prognostic and monitoring tools to help guide the management of Systemic Autoim-mune Rheumatic Diseases.

GRIFOLS Av. de la Generalitat 152-158Sant Cugat del Valles08174SpainBooth #: 07http://www.grifols.comGrifols is a global healthcare company with more than 75 years of history improving the health and well-be-ing of people around the world. We produce essential plasma medicines for patients and provide hospitals, pharmacies, and healthcare professionals with the tools, information, and services they need to efficiently deliver expert medical care. Our three divisions–Bioscience, Diagnostic, and Hospital–develop, produce, and market innovative products and services available in more than 100 countries. The Diagnostic Division advances patient care with innovative diagnostic solutions that improve the detection and management of disease and simplify laboratory operations.

17


HUMAN Diagnostics Worldwide Max-Planck-Ring 21Wiesbaden65205GermanyBooth #: 02http://www.human.deHUMAN is a global player in the IVD industry providing a comprehensive portfolio of high quality products, combined with a broad distribution, service and support network worldwide. Discover our autoimmune diagnostic product line consisting of ELISA, rapid latex assays and Line Immuno Assays (LIA) together with automation solutions. Explore especially the innovative LIA concept, the ideal tool for screening and dif-ferential diagnosis. With the new fully automated LIA system, HumaBlot 44FA we provide not only solutions for high-throughput needs but we also ensure quality assurance requirements. Visit us, discuss with our experts and ask for your personal demonstration.

Inova Diagnostics Inc 9900 Old Grove RoadSan Diego92131USABooth #: 03http://www.inovadx.comInova Diagnostics is redefining the boundaries of autoimmune testing. Inova integrates the autoimmune laboratory with systems and instruments, including NOVA View®, a digital approach to reading and ar-chiving IFA images, BIO-FLASH®, a rapid-response chemiluminescent analyzer, QUANTA-Lyser®, a family of EIA/IFA processors for increased flexibility and efficiency, and QUANTA Link®, a centralized network to make workflow management easy. Inova also offers a comprehensive menu of high quality NOVA Lite® IFA, QUANTA Lite® ELISA, and QUANTA Flash® CIA test kits for autoimmune diseases. Laboratories, clinicians and patients benefit from the excellent technical expertise, support and service offered by Inova Diagnostics.

MEDIPAN GMBH Ludwig-Erhard-Ring 3Dahlewitz15827GermanyBooth #: 06http://ww.medipan.deMEDIPAN founded 1992, is a leading company in development, manufacturing and international distribution of in vitro diagnostic tests. The main fields are the diagnosis of thyroid disease, diabetes type 1, systemic rheumatic diseases and other autoimmune disorders. MEDIPAN invented the AKLIDES® system, a platform technology for digital immunofluorescence. This technology is used for automated evaluation of cell and bead based immunofluorescence tests. A new application here is the detection of DNA damage caused by radiation, oxidative stress or drugs. Our company is an accepted and innovative partner for laboratories and physicians worldwide.

18

Trinity Biotech plc IDA Business Park, Southern Cross RoadBray, Co.WicklowA98H5C8IrelandBooth #: 08http://www.trinitybiotech.com/Trinity Biotech plc specialises in the development, manufacture and marketing of clinical diagnostic products. Test kits manufactured include clinical laboratory and point-of-care segments of the diagnostics market to detect autoimmune disorders, infectious diseases, sexually transmitted diseases and haemo-globin disorders. Trinity Biotech offers a comprehensive portfolio of industry leading autoimmune assays: Immunofluorescence (IFA), ELISA, Line Immunoassay (LIA) and Western Blot including unique reference laboratory-testing services. Combining these industry leading assays with complete laboratory automation, Trinity Biotech offers The Total Solution in Autoimmunity.

19




5tH LAtIN

AM


Scientific Program

Sunday, 26 November 2017

laca.kenes.com

21


SUNDAY, 26 NOVEMBER, 201712:55 - 15:00 Grand Coral 1

COURSE: Clinical Immunology Course 1 (Spanish, no translation)

PART 1: THE INTERACTION BETWEEN EXTERNAL AND INTERNAL FACTORS FOR THE DEVELOPMENT OF AUTOIMMUNE DISEASES

Chair: J.M. Anaya (Colombia) 1

Chair: L.J. Jara Quezada (Mexico) 2

12:55 OPENING WORDS 3

Y. Shoenfeld (Israel)

13:00 ZIKA VIRUS INFECTION AND AUTOIMMUNE NEUROLOGICAL SYNDROMES 4

C. Ramirez Santana (Switzerland)

13:30 CHIKUNGUNYA VIRUS INFECTION: LATIN AMERICAN EXPERIENCE 5

O. Vera Lastra (Mexico)

14:00 IMMUNE NEURO-ENDOCRINE INTERACTIONS AND AUTOIMMUNE RHEUMATIC DISEASES 6

L.J. Jara Quezada (Mexico)

14:30 THE INTERACTION BETWEEN GENES AND AUTOIMMUNE DISEASES 7

J.M. Anaya (Colombia)

15:00 - 15:30 Exhibition Area

Coffee Break

22

Sunday, 26 November, 2017

15:30 - 17:30 Grand Coral 1

COURSE: Clinical Immunology Course 2 (Spanish, no translation)

PART 2: MODULATION OF THE IMMUNE RESPONSE

Chair: C. Galarza-Maldonado (Ecuador) 8

Chair: R.A. Levy (Brazil) 9

15:30 BELIMUMAB AND OTHER ANTI BAFFS 10

M. Scheinberg (Brazil)

16:00 RITUXIMAB AND OTHER ANTI-B CELL ANTIBODIES - LATIN AMERICAN EXPERIENCE 11

C. Galarza-Maldonado (Ecuador)

17:00 PRE-AUTOIMMUNITY: A UNIQUE OPPORTUNITY FOR UNDERSTANDING AND MODULATING AUTOIMMUNITY 12

L.E. Andrade (Brazil)

17:30 - 20:00 Grand Coral 1

PLENARY SESSION IN ENGLISH: Opening Ceremony and Keynote Lecture Followed by Welcome Reception in the Exhibition Area

23




5tH LAtIN

AM


Scientific Program


laca.kenes.com

24www.autoimmunity-network.com

The Online Community forall Physicians, Researchersand Autoimmunologists

The Autoimmunity Network is a dynamic social community of international medical professionals who share the common goal of exchanging knowledge about autoimmune diseases.

Join Today!

25


MONDAY, 27 NOVEMBER, 20178:00 - 10:00 Grand Coral 1

PLENARY SESSION IN ENGLISH: Plenary Session 1: Antiphospholipid Syndrome

Chair: R.A. Levy (Brazil) 13

Chair: Y. Sherer (Israel) 14

8:00 THE HEART AND APS 15

M.C. Amigo (Mexico)

8:24 RENAL INVOLVEMENT IN THE ANTIPHOSPHOLIPID SYNDROME 16

R. Cervera (Spain)

8:48 NEW AND UPCOMING TREATMENTS FOR APS 17

R.A. Levy (Brazil)

9:12 COMPLEMENT ACTIVATION IN RELATION TO LUPUS AND ANTIPHOSPHOLIPID ANTIBODIES: INSIGHTS FROM THE CLINICAL LABORATORY 18

T. Dervieux (USA)

9:36 PHOSPHATIDYLCHOLINE (PC) AND THE MEMBRANE DYNAMICS 19

E. Kane (USA)


Coffee Break, Exhibition & Poster Viewing

www.autoimmunity-network.com

The Online Community forall Physicians, Researchersand Autoimmunologists

The Autoimmunity Network is a dynamic social community of international medical professionals who share the common goal of exchanging knowledge about autoimmune diseases.

Join Today!

26

Monday, 27 November, 2017

10:40 - 12:40 Grand Coral 1

PARALLEL SESSION IN ENGLISH (no translation): Parallel Session 1: Systemic Autoimmune Diseases

Chair: L. Mouthon (France) 20

Chair: E.R. Soriano (Argentina) 21

10:40 TREATMENT OF ANCA-ASSOCIATED VASCULITIS 22

L. Mouthon (France)

11:00 RENAL INVOLVEMENT OF ANCA VASCULITIS 23

E.R. Soriano (Argentina)

11:20 USEFULNESS OF CARDIAC MAGNETIC RESONANCE IN THE CARDIOVASCULAR EVALUATION OF SYSTEMIC SCLEROSIS 24

E. Cairoli (Uruguay)

11:40 METABOLIC SYNDROME, AUTOIMMUNITY AND AUTOIMMUNE RHEUMATIC DISEASES 25

G. Medina (Mexico)

12:00 RENAL, VASCULAR AND CENTRAL NERVOUS SYSTEM MECHANISMS OF HYPERTENSION INDUCED BY IMMUNITY 26

B. Rodriguez Iturbe (Venezuela)

12:20 MULTIPLE SCLEROSIS - A CLASSICAL AUTOIMMUNE DISEASE 27

D. Karussis (Israel)

27


10:40 - 12:40 Grand Coral 2

PARALLEL SESSION IN SPANISH (no translation): Parallel Session 2: Autoantibody Updates

Chair: L.E. Andrade (Brazil) 28

Chair: R. Cervera (Spain) 29

10:40 WHY AUTOANTIBODY STANDARDIZATION IS SO CRITICAL FOR THE DIAGNOSIS OF AUTOIMMUNE DISEASES 30

L.E. Andrade (Brazil)

11:00 COULD THE IMMUNE SYSTEM BE RESET IN EARLY AUTOIMMUNE DISEASES? 31

A. Babini (Argentina)

11:20 DIFFERENCES AMONG ACPA POSITIVE AND ACPA NEGATIVE RHEUMATOID ARTHRITIS PATIENTS 32

J.A. Gómez-Puerta (Colombia)

11:40 DFS INTERPRETATION 33

M. Vazquez del Mercado (Mexico)

12:00 NEW AUTOANTIBODIES IN DERMATOMYOSITIS: SEROLOGICAL SPECIFICITIES AND PHENOTYPE CORRELATIONS 34

V.S. Vilela (Brazil)

12:20 REPORT OF CASES OF THE BENEFIT OF MIND-BODY THERAPY IN SEVERE AUTOIMMUNE DISEASES 35

J.L. Aguilar, S.M. Salinas (Peru)

12:30 POLYAUTOIMMUNITY 36

C. Malagón (Colombia)


Lunch Break, Exhibition & Poster Viewing

28


13:50 - 15:50 Grand Coral 1

Free Communications 1 (English)

Chair: M. Scheinberg (Brazil) 37

Chair: G. Pons-Estel (Argentina) 38

Chair: M. Alarcon Riquelme (Spain) 39

13:50 DEXAMETHASONE AND MONOPHOSPHORYL LIPID A REMOVE DISEASE-ASSOCIATED TRANSCRIPTIONAL SIGNATURES AND INDUCE A DISTINCTIVE REGULATORY PROFILE ON MONOCYTE-DERIVED DENDRITIC CELLS FROM RHEUMATOID ARTHRITIS PATIENTS 40

P. García-González, K. Schinnerling, A. Sepúlveda, J. Maggi, L. Soto, O. Neira, A.M. Mehdi, H.J. Nel, D. Catalán, R. Thomas, R.A. Verdugo, J.C. Aguillón (Chile)

14:00 AUTOANTIBODY AND CYTOKINE CLUSTERS IN RHEUMATIC AUTOIMMUNITY 41

N. Molano-Gonzalez, Y. Pacheco, A. Espejo-Mojica, D.M. Monsalve, J.E. Barahona-Correa, M. Rojas, Y. Rodríguez, J. Saavedra, D. González-Bravo, M. Rodríguez-Jimenez, R.D. Mantilla, C. Ramírez-Santana, J.M. Anaya (Colombia)

14:10 RHEUMATIC AND THYROID AUTOIMMUNITY IN PATIENTS WITH ZIKA VIRUS DISEASE 42

D.M. Monsalve, Y. Pacheco, Y. Acosta-Ampudia, Y. Rodríguez, C. Ramírez-Santana, J.M. Anaya (Colombia)

14:20 THE AUTOIMMUNE ECOLOGY 43

C. Ramirez Santana (Colombia)

14:30 DIFFERENTIATION BETWEEN APS PATIENTS AND ANTIPHOSPHOLIPID ANTIBODY-POSITIVE CARRIERS BY A NOVEL LINE IMMUNOASSAY – DOES BETA2 GLYCOPROTEIN I DOMAIN 1 REACTIVITY MATTER? 44

D. Roggenbuck, P. Schierack, M. Mahler, P. Marcor, M.O. Borghi, P.L. Meroni (Germany)

14:40 CHIKUNGUNYA EPIDEMIC IN COLOMBIA. PART 1 OF 5: SOCIODEMOGRAPHIC, CLINICAL CHARACTERISTICS AND JOINT INVOLVEMENT 45

J.C. Rueda, J.I. Angarita, A.M. Santos, E.L. Saldarriaga, I. Pelaez-Ballestas, J. Londono (Colombia)

14:50 CHIKUNGUNYA EPIDEMIC IN COLOMBIA. PART 3 OF 5: IMPROVED CLINICAL SCENARIO FOR CHIKV DIAGNOSIS 46


15:00 ERAP POLYMORPHISMS AND ITS ASSOCIATION WITH HLA-B15 AND HLA-B27 POSITIVE SPONDYLARTHRITIS PATIENTS 47

J. Londono, A.M. Santos, J.C. Rueda, P. Peña, I. Briceño, E.L. Saldarriaga, J.I. Angarita, E. Calvo, M. Avila, N. Martinez-Rodriguez, J.F. Medina (Colombia)

29


15:10 CHIKUNGUNYA VIRUS CAN INDUCE BOTH SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS: INCIDENT CASES FROM A MEXICAN COHORT OF PATIENTS WITH PREVIOUS CHIKUNGUNYA FEVER 48

J. Sepulveda-Delgado, R. Danis-Lozano, I. Fernandez-Salas, M. Benitez, O.L. Vera-Lastra (Mexico)

15:20 DOWN-REGULATION OF AUTOREACTIVE T AND B LYMPHOCYTES BY SELECTIVE THERAPY IN HUMANIZED MURINE SCID MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS 49

N. Mihaylova, S. Bradyanova, P. Chipinski, E. Ivanova-Todorova, D. Kyurkchiev, J. Prechl, M. Herbáth, A. Tchorbanov (Bulgaria)

15:30 ANTI-DOMAIN 1 BETA2 GLYCOPROTEIN I ANTIBODIES PREDICT MULTIPLE AUTOANTIBODY POSITIVITY IN ANTIPHOSPHOLIPID SYNDROME 50

N. Heikal, T. Martins, J. Miller, A.E. Tebo (USA)

15:40 EARLY EXPRESSION OF B7-H3 DURING PROGRESSION OF HEPATOCELLULAR PRENEOPLASTIC LESION IN RAT MODEL 51

G. Carrasco-Torres, Y. Vázquez-Cóbix, S. Villa-Treviño, M.D.L.A. Romero-Tlalolini, R. Baltiérrez-Hoyos, V.R. Vásquez-Garzón (Mexico)

30


13:50 - 15:50 Grand Coral 2

Free Communications 2: Barcelona Clínic Autoimmunity- Alumni (Bilingual Session)

Chair: R. Cervera (Spain) 52

Chair: M. Ugarte-Gil (Peru) 53

Chair: E. Cairoli (Uruguay) 54

13:50 BARCELONA CLINIC AUTOIMMUNITY 55

E. Cairoli (Uruguay)

14:05 GLADEL 2.0 56

M. Ugarte-Gil (Peru)

14:20 A NATIONAL GOVERNMENT EXPERIENCE 57


14:35 CHILEAN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS SHOW INCREASED SERUM LEVELS OF IL-21 (SPANISH) 58

D. Hirigoyen, A. Alvarez, R. Montalva, R. Naves, M. Iruretagoyena, P. Burgos (Chile)

14:45 COMPARISON OF GESTATIONAL RESULTS OF PATIENTS WITH THROMBOTIC APS TO THOSE WITH APL-NEGATIVE DEEP VENOUS THROMBOSIS 59

G. De Jesus, N. De Jesus, T. Lessa dos Anjos, N. Ney, S. Monteiro, P. Guyt Rebelo, F. Cunha dos Santos, V. Vilela, R. Levy (Brazil)

14:55 IMPORTANCE OF SERUM TITERS OF ANTIBODIES AGAINST DOMAIN 1 OF B2 GLYCOPROTEIN 1 60

J.A. Gómez-Puerta, T. Urrego, A. Hernández, S. Ruiz, C. Rua, J. Duque Botero, M. Velásquez, A.P. Cadavid, A. Vanegas-García, C.H. Muñoz, L.A. González, G. Vásquez (Colombia)

15:05 VCAM-1 AND TWEAK AS BIOMARKERS FOR MEMBRANOUS LUPUS NEPHRITIS 61

T. Urrego, B.L. Ortiz Reyes, G. Aroca, A.L. Vanegas-García, A.A. Cadena Bonfanti, L. Almendrales, C.H. Muñoz, L.A. González, A. Iglesias, G. Vásquez, J.A. Gómez-Puerta (Colombia)

15:15 VITAMIN D SUPPLEMENTATION REDUCES TLR7 EXPRESSION IN B CELLS FROM SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS 62

P. Burgos, D. Hirigoyen, R. Montalva, A. Alvarez, R. Naves, M. Iruretagoyena (Chile)

15:25 ANTIPHOSPHOLIPID SYNDROME LONG TERM FOLLOW UP: REAL LIFE EXPERIENCE OF A SINGLE CENTRE (SPANISH) 63

R.M. Serrano Morales, G. Pons-Estel, G. Espinosa, R. Quintana, R. Cervera (Spain)

15:35 MEMORIES FROM THE HOSPITAL CLINIC OF BARCELONA 64

R. Cervera (Spain)

31




16:30 - 18:00 Grand Coral 1

PLENARY SESSION IN ENGLISH: Plenary Session 2: Genomics, Autoimmunity and Autoimmune Diseases in Latin America

Chair: J. Granados Arriola (Mexico) 65

Chair: M. Alarcon Riquelme (Spain) 66

16:30 COMMONALITIES AMONG AUTOIMMUNE DISEASES 67

J.M. Anaya (Colombia)

16:50 AUTOIMMUNE DISEASE STRATIFICATION 68

M. Alarcon Riquelme (Spain)

17:20 HLA AND DISEASE 69

J. Granados Arriola (Mexico)

17:40 GENETICS AND EPIGENETICS IN AUTOIMMUNITY 70

P. Kane (USA)

32


33




5tH LAtIN

AM


Scientific Program


laca.kenes.com

34

FLORENCE, ITALY, 14-16 MARCH 2019cora.kenes.com

5TH INTERNATIONAL CONGRESS ON

CONTROVERSIESIN RHEUMATOLOGY& AUT IMMUNIT

SEE YOU IN FLORENCE

35


TUESDAY, 28 NOVEMBER, 20178:00 - 10:00 Grand Coral 1

PLENARY SESSION IN ENGLISH: Plenary Session 3: Autoimmunity in Latin America

Chair: L.J. Jara Quezada (Mexico) 71

Chair: M. Cardiel (Mexico) 72

8:00 PRACTICAL ASPECTS IN RHEUMATOID ARTHRITIS TREATMENT IN LATIN AMERICA 73

M. Cardiel (Mexico)

8:24 AUTOIMMUNITY IN LATIN AMERICA: SCIENTIFIC PRODUCTIVITY IN THIS CENTURY 74

L.J. Jara-Quezada, E. Zurita, L.E. Deustua, G. Medina (Mexico)

8:48 CLINICAL MANIFESTATIONS OF GLUTEN RELATED DISORDERS 75

P. Abumohor (Chile)

9:12 THE AUTOIMMUNE ECOLOGY 76

C. Ramirez-Santana (Colombia)

9:36 ANTIPHOSPHOLIPID SYNDROME AND PREGNANCY: 20 YEARS OF EXPERIENCE IN ECUADOR 77




FLORENCE, ITALY, 14-16 MARCH 2019cora.kenes.com

5TH INTERNATIONAL CONGRESS ON

CONTROVERSIESIN RHEUMATOLOGY& AUT IMMUNIT

SEE YOU IN FLORENCE

36

Tuesday, 28 November, 2017

10:40 - 12:40 Grand Coral 1

PARALLEL SESSION IN ENGLISH (no translation): Parallel Session 3: Infection in Autoimmunity

Chair: L.R. Espinoza (USA) 78

Chair: C. Mendoza - Pinto (Mexico) 79

10:40 HIV - OVERVIEW AND HOW IT AFFECTS THE NATURAL HISTORY, COURSE, AND APPROACH TO THERAPY OF AUTOIMMUNE DISORDERS 80

L.R. Espinoza (USA)

11:00 HUMAN PAPILLOMAVIRUS INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS 81

C. Mendoza - Pinto (Mexico)

11:20 THE ROLE OF INFECTIOUS DISEASES IN THE CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME 82

C. Cervera (Canada)

11:40 IS CHIKUNGUNYA VIRUS INFECTION A RISK FACTOR FOR DEVELOPING RHEUMATOID ARTHRITIS? 83


12:00 THE PARADOXICAL EFFECT OF INFECTIOUS DISEASES ON AUTOIMMUNITY: MAIN DIFFERENCE BETWEEN RICH AND POOR COUNTRIES 84

J.O. Garcia-Mendez (Mexico)

12:20 INFECTION IN AUTOIMMUNE PATIENTS; A CENTER EXPERIENCE 85

C. Vasconcelos (Portugal)

37


10:40 - 12:40 Grand Coral 2

PARALLEL SESSION IN SPANISH (no translation): Parallel Session 4: Systemic Lupus Erythematosus

Chair: M. Ugarte-Gil (Peru) 86

Chair: G. Pons-Estel (Spain) 87

10:40 FLARES IN SLE. PREDICTORS AND CONSEQUENCE 88

M. Ugarte-Gil (Peru)

11:00 ANTIMALARIALS OLD DRUG, NEW INDICATIONS FOR SLE 89

G. Pons-Estel (Spain)

11:20 EPIDEMIOLOGY OF LUPUS IN LATIN AMERICA 90

E.R. Soriano (Argentina)

11:40 URINARY BIOMARKERS IN SLE 91

J.A. Gómez-Puerta (Colombia)

12:00 PARTICIPATION OF IL-2 IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS 92

J. Alcocer Varela (Mexico)

12:20 ASSOCIATION OF JUVENILE SYSTEMIC LUPUS ERYTHEMATOSOUS( JSLE) WITH ANOTHER AUTOIMMUNE DISEASES .(AIDS) 93

C. Malagón, M. Gomez, A. Mosquera, R. Yepez, T. Gonzalez, Vargas CA (Colombia)

12:30 ROBUST STRATIFICATION OF LUPUS BASED ON LONGITUDINAL GENE EXPRESSION DATA AND DISEASE ACTIVITY PATTERNS 94

D. Toro Dominquez, M.E. Alarcón-Riquelme, P. Carmona-Saez (Spain)


Lunch Break, Exhibition & Poster Viewing

38


13:50 - 15:50 Grand Coral 1

Free Communications 3 (English)

Chair: C. Edwards (United Kingdom) 95

Chair: S. Appenzeller (Brazil) 96

13:50 EVALUATION OF ANTI-DOUBLE STRANDED DNA ANTIBODIES IN THE MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS 97

T. Dervieux, C. Ibarra, C.B. Chelsea Bentow, M.A.A. Aure, T. O’Malley, J. Conklin, M. Mahler (USA)

14:00 BACTEROIDES PREDOMINANCE IN FECAL MICROBIOTA OF CELIAC DISEASE AND TYPE 1 DIABETES CHILDREN FROM NORTHWEST MEXICO 98

A.M. Calderon de la Barca, R. Sigala-Robles, M.E. Mejia-Leon (Mexico)

14:10 ENDOTHELIAL DYSFUNCTION BY MICROPARTICLES FROM SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS 99

L. Atehortúa, M. Rojas, G. Vásquez, C.H. Muñoz, A. Vanegas-García, R.A. Posada-Duque, D. Castaño (Colombia)

14:20 AUTOPHAGY AND RECEPTORS OF PROLACTIN IN REGULATORY T AND B LYMPHOCYTES IN SYSTEMIC LUPUS ERYTHEMATOSUS: ASSOCIATION WITH LUPUS NEPHRITIS 100

E. Zurita, L.J. Jara, A. Duran, A. Rodriguez, A. Sanchez, R. Bustamante, M.A. Saavedra, C. Arroyo, G. Medina (Mexico)

14:30 PERSONAL REGISTRY BY MOBILE APP FOR PATIENTS WITH RHEUMATOID ARTHRITIS, A PILOT STUDY OF TRACER 101

J.C. Lin, C.Y. Lin, C.S. Wu (Taiwan R.O.C.)

14:40 ENVIRONMENTAL ANTIGEN-RECOGNIZING AUTOANTIBODIES FROM BRAZILIAN PEMPHIGUS FOLIACEUS PATIENTS CROSS-REACT WITH DIVERSE KERATINOCYTE ADHESION MOLECULES 102

Y. Qian, L. Lin, D. Culton (USA)

14:50 SERUM CXCL16 LEVELS IN SEROPOSITIVE RHEUMATOID ARTHRITIS PATIENTS BEFORE AND AFTER TREATMENT WITH DMARDS 103

R. Ramamoorthy, D.R. Shankerlingam, S. Vengudusamy (India)

15:00 NEUTROPHILS FROM SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ARE MORE SUSCEPTIBLE TO PRODUCE EXTRACELLULAR TRAPS, CORRELATING WITH THE ACTIVATION STATE OF THEIR PLASMACYTOID DENDRITIC CELLS 104

H. Torres-aguilar, J.I. Bibiano-Baños, S.A. Sosa-Luis, S.R. Aguilar-Ruiz, L.A. Hernández-Osorio, J. Vargas-Arzola (Mexico)

15:10 FLIGHTS AND AUTOIMMUNITY. ARE THERE POSSIBLE INTERFERENCES? 105

J. Torres-Ruiz, A. Sulli, M. Cutolo, Y. Shoenfeld (Mexico)

39


15:20 SMALL FOR GESTATIONAL AGE NEWBORNS IN PREGNANCIES OF WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS 106

B. Rodrigues (Brazil)

15:30 A ROLE FOR THE CXCL17/CXCR8 AXIS IN GASTROINTESTINAL INFLAMMATION, AUTOIMMUNITY AND OBESITY 107

A. Zlotnik, C. Herrera, H.T. Nguyen, J. Catalan, M. Hernandez (USA)

15:40 EXPRESSION ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISMS RS179008, RS2004640 AND RS1800975 IN MAYAN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS 108

G. Valencia Pacheco, Y.E. Nakazawa Ueji, L.J. González Herrera, A.V. Angulo Ramirez, R.F. López Villanueva, G. Perez Mendoza, N.A. Rivero Cardenas (Mexico)

40


13:50 - 15:50 Grand Coral 2

Free Communications 4 (Bilingual)

Chair: B. Rodriguez Iturbe (Venezuela) 109

Chair: C. Putterman (USA) 110

13:50 DIFFERENCES IN CLINICAL PRESENTATION BY GENDER IN COLOMBIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 111

S. Herrera, M.A. Alzate, D. Hernandez-Parra, D. Echeverry, J.C. Salazar-Uribe, P. Ortiz-Salazar, R. Pineda (Colombia)

14:00 CLINICAL AND SEROLOGICAL DIFFERENCES BETWEEN EARLY AND LATE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS 112

S. Herrera, M.A. Alzate, D. Hernandez-Parra, D. Echeverry, J.C. Salazar-Uribe, P. Ortiz-Salazar, R. Pineda (Colombia)

14:10 PROBIOTIC SACCHAROMYCES BOULARDII PLUS METRONIDAZOLE IN SMALL INTESTINAL BACTERIAL OVERGROWTH AND GASTROINTESTINAL SYMPTOMS IN SYSTEMIC SCLEROSIS 113

G. García-Collinot, E.O. Madrigal-Santillán, D.H. Montes-Cortes, R.A. Carranza-Muleiro, O.L. Vera-Lastra, L.J. Jara (Mexico)

14:20 SEVERE GENERAL SYMPTOMS AND DESNUTRITION ARE RISK FACTORS FOR MORTALITY IN MEXICAN PATIENTS WITH SYSTEMIC SCLEROSIS 114

M.P. Cruz-Domínguez, G. García-Collinot, M.A. Saavedra, D.H. Montes-Cortes, R.A. Carranza-Muleiro, O.L. Vera Lastra, L.J. Jara (Mexico)

14:30 DIFFERENCES IN MORTALITY BETWEEN PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME ACCORDING DAMAGE INDEX IN ANTIPHOSPHOLIPID SYNDROME: NESTED CASE-CONTROL STUDY 115

L.A. Martinez-Martínez, J. Fonseca-Basurto, M.C. Amigo, M. Chacon (Mexico)

14:40 TH1, TH2 AND TH17 LYMPHOID SUBPOPULATIONS IN PRIMARY ANTIPHOSPHOLIPID SYNDROME 116

G. Medina, O.I. Flórez Durante, L.A. Montiel Cervantes, E. Reyes Maldonado, R. Molina Aguilar, U. Angeles Garay, L.J. Jara (Mexico)

14:50 EVALUATION OF SOLUBLE CTLA4 LEVELS IN MULTIPLE SCLEROSIS: ASSOCIATION WITH CLINICAL AND HEMATOLOGICAL PARAMETERS 117

S. Muñoz-Barrios, G. Playas-Pérez, R. Fernández-Acuña, Y.G. Salgado-Molina, M. Calixto-Gálvez, M.O. Uriostegui-Acosta, C. González-Calixto, A. Ramírez-Peralta, M. Vázquez-Villamar, I.P. Guzmán-Guzmán, J.F. Muñoz-Valle (Mexico)

15:00 ANTI DFS-70 ANTIBODIES: CONFIRMATION OF THE ANTINUCLEAR ANTIBODIES (ANA) DENSE FINE SPECKLED PATTERN (DFS) 118

N. Rodriguez Sisniega, C. Buzzi, N. Correa, M. Garay, A. Márquez, R. Ballesté (Uruguay)

41


15:10 GENETIC AND SEROLOGICAL LINKAGE BETWEEN KAWASAKI AND CELIAC DISEASE IN BRAZILIAN CHILDREN 119

A.S. Domingues, C.M.R. Magalhães, R.H. Uenishi, I.M.S.N. Teotônio, L. Gandolfi, Y.K.M. Nóbrega, R. Pratesi, N. Selleski (Brazil)

15:20 POPULATION BASED SCREENING FOR ACPA: A STEP IN THE PATHWAY TO THE PREVENTION OF RHEUMATOID ARTHRITIS? 120

M. Mahler (USA)

15:30 AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IMPROVES THE NEUROLOGICAL CONDITION OF PERSONS WITH MULTIPLE SCLEROSIS (MS): THE MEXICAN EXPERIENCE 121

A. Ruiz-Arguelles, G. Ruiz-Arguelles, J.C. Olivares-Gazca, I. Murrieta, D. Blumenkron-Marroquin, D. Gomez-Almaguer, E. Gonzalez-Lopez, G. Ruiz-Delgado, A. Gomez-De-Leon (Mexico)

15:40 MOLECULAR STRATIFICATION OF AUTOIMMUNE DISEASES BASED ON EPIGENETIC PROFILES 122

G. Barturen, M. Kerick, D. Alvarez-Errico, R. Quirantes, E. Carnero, D. Gemperline, E. Dow, L. Beretta, J.O. Pers, Y. Renaudineau, J. Frostegard, M. Juárez, P. Clinical Consortium / Flow Cytometry Group, S. Rao, C. Chamberlain, J. Wojcik, A. Segura, J. Martin, E. Ballestar, M.E. Alarcón-Riquelme (Spain)



42


16:30 - 18:00 Grand Coral 1

PLENARY SESSION IN ENGLISH: Plenary Session 4: The ASIA Syndrome

Chair: O. Vera Lastra (Mexico) 123

Chair: M. Martinez-Lavin (Mexico) 124

16:30 AUTOIMMUNE/INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS - AN UPDATE 125

Y. Shoenfeld (Israel)

16:54 AUTOIMMUNE/INFLAMMATORY SYNDROME INDUCED BY MINERAL OIL. A HEALTH PROBLEM IN LATIN AMERICA 126


17:16 HPV VACCINE AND FIBROMYALGIA 127

M. Martinez-Lavin (Mexico)

17:38 VACCINES AND AUTOIMMUNITY IN CNS 128

D. Karussis (Israel)

43




5tH LAtIN

AM


Scientific Program

Wednesday, 29 November 2017

laca.kenes.com

44

Visit jrheum.org to view our new website

45


WEDNESDAY, 29 NOVEMBER, 20178:00 - 10:00 Grand Coral 1

PLENARY SESSION IN ENGLISH: Plenary Session 5: The Environment in Autoimmunity

Chair: M.E. Gershwin (USA) 129

Chair: M. García-Carrasco (Mexico) 130

8:00 VITAMIN D AND AUTOIMMUNE DISEASES 131

M. García-Carrasco (Mexico)

8:24 SEX, GENETICS AND THE ENVIRONMENT 132

M. Gershwin (USA)

8:48 EMERGING AUTOIMMUNITY IN DOMESTIC ANIMALS 133

L. Gershwin (USA)

9:12 OBESITY, AUTOIMMUNITY, AND AUTOIMMUNE DISEASES 134

M. Vazquez del Mercado (Mexico)

9:36 IMPROVED ANA SCREENING ALGORITHM USING A NOVEL DFS70 KNOCK OUT HEP-2 IIF 135

K. Malyavantham (USA)


Coffee Break & Exhibition

Visit jrheum.org to view our new website

46

Wednesday, 29 November, 2017

10:40 - 12:40 Grand Coral 1

PLENARY SESSION IN ENGLISH: Plenary Session 6: Advances in Autoimmune Disease Therapy

Chair: M. Scheinberg (Brazil) 136

Chair: C. Putterman (USA) 137

10:40 THE FUTURE LANDSCAPE OF BIOSIMILARS IN RHEUMATOLOGY 138

M. Scheinberg (Brazil)

11:00 TARGETING MACROPHAGES FOR THE TREATMENT OF LUPUS NEPHRITIS (ANIMAL MODEL/TRANSLATIONAL) 139

C. Putterman (USA)

11:20 ROLE OF ANTIBODIES AND CYTOKINES IN CNS MANIFESTATIONS IN SLE 140

S. Appenzeller (Brazil)

11:40 DOSE TAPERING OF BIOLOGICAL THERAPIES: SAFE OR NOT? 141

C. Edwards (United Kingdom)

12:00 SYNTHETIC AND BIOLOGIC DMARDS DURING PREGNANCY AND LACTATION 142

R.A. Levy (Brazil)

12:20 THE PRESENT OF DENDRITIC CELLS-BASED THERAPY FOR AUTOIMMUNITY 143

J.C. Aguillón (Chile)

47




5tH LAtIN

AM


Poster Session 1


laca.kenes.com

49


Board number

MONDAY, 27 NOVEMBER, 2017

ANTIPHOSPHOLIPID SYNDROME TOWARDS THE THIRD DECADE

01 INFLUENCE OF ANTIPHOSPHOLIPID ANTIBODIES IN PLATELET’S AGGREGATION TESTS 144

H.L. Mesquita, L.D.S. Caputo, C.P. Vanelli, J.O.D.A. Corrêa, M.R.A. Azevedo (Brazil)

02 DETECTION OF NON-BILAYER PHOSPHOLIPID ARRANGEMENTS ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME 145

M.F. García-Gutiérrez, M.T. Hernández-Martínez, S. Hernández-Doño, V.H. Tovar-Méndez, R. Hernández-Pando, J. Jakez-Ocampo, K. Landa-Saldívar, C. Wong-Baeza, S. Sánchez-Barbosa, J. Granados, I. Baeza-Ramírez (Mexico)

03 PREGNANCY IS THE PRINCIPAL RISK FACTOR FOR THROMBOTIC EVENT AT ANTIPHOSPHOLIPID SYNDROME ONSET 146

G. Medina, O.I. Flórez-Durante, M.A. Saavedra-Salinas, L.J. Jara (Mexico)

ANTI-TNFs AND AUTOIMMUNITY

04 AN EXAMINATION OF THE SERUM LEVELS OF INFLIXIMAB (IFX) AND ANTI-IFX ANTIBODIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A PRIVATE HOSPITAL IN BRAZIL 147

K.C. Kampa, J.L. Carvalho, D.B.G. Morsoletto, M.R. Loures, A. Pissaia Junior, R.B. Nones, C.A.P. Ivantes, M.L.A. Pedroso (Brazil)

ARBOVIROSIS, ARTHRITIS, AND IMMUNE RESPONSE IN LATIN AMERICA

05 BEYOND THE CHIKUNGUNYA FEVER: REPORT OF 62 CASES OF RHEUMATIC DISEASES. DOMINICAN EXPERIENCE TWO YEARS AFTER THE EPIDEMIC 148

R. Vásquez-Colón, J. Then, K. Franco, P. Gottschalk, C. Tineo, M. Alvarez, E. Loyo (Dominican Republic)

06 DYSAUTONOMIA IN PATIENTS WITH ZIKA VIRUS DISEASE 149

Y.A. Rodriguez Velandia, D.M. Monsalve, Y. Acosta Ampudia, N. Molano, C. Ramirez Santana, J.M. Anaya (Colombia)

50

Posters - Monday, 27 November, 2017

Board number

07 CHIKUNGUNYA EPIDEMIC IN COLOMBIA. PART 2 OF 5: AGREEMENT STUDY AND EXPERT CONSENSUS FOR THE CLINICAL PICTURE OF CHIKV INFECTION 150

J.C. Rueda, J.I. Angarita, C. Pinzon, A.M. Santos, E.L. Saldarriaga, J.M. Rueda, D.L. Saaibi, E. Forero, I. Pelaez-Ballestas, P.X. Pavía, J. Londono (Colombia)

08 CHIKUNGUNYA EPIDEMIC IN COLOMBIA. PART 4 OF 5: PERFORMANCE OF IMMUNOGLOBULIN M AND G ANTIBODIES AGAINST CHIKUNGUNYA VIRUS (CHIKV) BY ENZYME-LINKED IMMUNOSORBENT (ELISA) TECHNIQUE 151


09 CHIKUNGUNYA EPIDEMIC IN COLOMBIA. PART 5 OF 5: ASSOCIATION OF HUMAN LEUKOCYTE A, B AND DR ANTIGENS IN PATIENTS WITH CHIKUNGUNYA VIRUS INFECTION 152


ARTERIAL HYPERTENSION AND THE IMMUNE SYSTEM

10 HERBAL MEDICINE TODAY: CLINICAL AND RESEARCH ISSUES 153

T.A. Mohammed (India)

CANCER AND AUTOIMMUNITY

11 PURPLE OF HENOCH SCHONLEIN AS AN INITIAL PRESENTATION OF MULTIPLE MYELOMA 154

L. Moranchel García, L.F. Pineda Galindo, O.L. Vera Lastra (Mexico)

12 PREVALENCE OF MALIGNANCY IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) AT CENTRO MEDICO NACIONAL 20 DE NOVIEMBRE ISSSTE MEXICO CITY. 155

B.I. Lopez Benjume, S. Muñoz Lopez, F. Irazoque Palazuelos, M.F. Morales Irazoque (Mexico)

13 HERBAL MEDICINE TODAY: CLINICAL AND RESEARCH ISSUES 156

M.A.B. Rahamani (India)

14 PD-L1 EXPRESSION IN 14 BIOPSY TISSUE SAMPLES OF USUAL INTERSTITIAL PNEUMONIA (IDIOPATHIC PULMONARY FIBROSIS) 157

D. Jovanovic, J. Markovic, S. Radojevic Skodric, S. Glumac, M. Kontic, V. Vucinic Mihailovic, V. Skodric Trifunovic, I. Vukanic, M. Roksandic Milenkovic, V. Ceriman (Serbia)

15 REGULATION BY THE TRANSCRIPTION FACTOR STAT3 IN THE IMMUNOPHENOTYPE MODULATION MONOCYTE-MACROPHAGE FROM M1 TO M2 GENERATE BY CULTURE SUPERNATANT OF PROSTATE CANCER CELLS 158

R. Solis-martinez (Mexico)

51


Board number

CENTRAL NERVOUS SYSTEM AND AUTOIMMUNITY; EYE, SMELL AND PSYCHIATRY

16 CLINICAL CHARACTERISTICS OF PATIENTS WITH SUSPECTED AUTOIMMUNE ENCEPHALITIS ACCORDING TO AUTOANTIBODIES STATUS 159

S. Barzón, R. De Elías, O. Kiener, V. Faustinelli, V. Jarmi (Argentina)

17 AN INCREASED LEVEL OF THE PROTEIN SERUM AMYLOID A WAS DETECTED BY PROTEOMIC ANALYSIS IN NEUROPSYCHIATRIC LUPUS ERYTHEMATOSUS SYSTEMIC (NPSLE) PATIENT’S SERUM. 160

B.L. Ortiz Reyes, N.P. Duarte Delgado, T.P. Lujan, A. Arbelaez Cortes, M. Restrepo Escobar, G. Vasquez (Colombia)

18 PREVALENCE OF FIBROMYALGIA, DEPRESSION AND BOTH IN PATIENTS WITH AUTOIMMUNE / INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS COMPARED TO PATIENTS WITH SYSTEMIC SCLEROSIS 161

O. Vera Lastra, P. Blas Hernández, A. Sánchez-Rodríguez, L.J. Jara (Mexico)

19 ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN REFRACTORY BEHCET UVEITIS: A SINGLE CENTER EXPERIENCE 162

Z. Yilmaz (Turkey)

DIAGNOSTIC MEASUREMENTS IN AUTOIMMUNITY

20 ADVANCES IN DIAGNOSTIC TESTS FOR LUPUS NEPHRITIS 163

C.P. Vanelli, O.D.S. Pereira Junior, J.O.A. Corrêa (Brazil)

21 PATIENTS WITH NON-AUTOIMMUNE DISEASES PRESENT A DIFFERENTPROFILE OF ANTI-CELL ANTIBODY TEST (INDIRECT IMMUNOFLUORESCENCE ON HEP-2 CELLS) REGARDING PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES 164

R. Agustinelli, S. Rodrigues, H. Mariz, M. Prado, L.E. Andrade (Brazil)

22 ESOPHAGEAL DISORDERS BY HIGH RESOLUTION MANOMETRY IN A GROUP OF PATIENTS WITH SYSTEMIC SCLEROSIS 165

S. Bernal-Macías, V. Parra-Izquierdo, F.A. Avila-Almanza, A.M. Leguizamon, V.A. Costa-Barney, A.C. Hani-Amador (Colombia)

23 INFLAMMATORY PARAMETERS “TGF-b, NEUTROPHIL/LYMPHOCYTE RATIO AND PLATELET/LYMPHOCYTE RATIO” IN NORMOVITAMINOSIS VS HYPOVITAMINOSIS D IN SYSTEMIC SCLEROSIS 166

M.D.P. Cruz-Domínguez, A.A. Reséndiz Albor, L. Manuel -Apolina, G. Collinot-García, L. Montiel-Cervantes, L.J. Jara-Quezada, R.A. Carranza Muleiro (Mexico)

52


Board number

24 WEAK AGREEMENT BETWEEN 18-FDG PET/CT AND THE INDIAN TAKAYASU ACTIVITY SCORE IN A MEXICAN SINGLE CENTER POPULATION 167

D. Hernandez-Lopez, A. Martinez-Martinez, D. Jimenez-Arenas, B. Rivera-Bravo, M.E. Soto-Lopez (Mexico)

25 AUTOINMUNE DISEASE IN THIRD LEVEL HOSPITAL 168

Y. Merida, R. Arreola, M. Herrera (Guatemala)

26 COMPARISON OF THE RELIABILITY OF 17 CELIAC DISEASE ASSOCIATED BIO-MARKERS TO REFLECT INTESTINAL DAMAGE 169

A. Lerner, P. Jeremias, S. Neidhöfer, M. Torsten (Germany)

27 EPITOPES OF HUMAN AND MICROBIAL TRANSGLUTAMINASES ARE SHARED BY CELIAC DISEASE SERA 170

T. Matthias, P. Jeremias, K. Prager, S. Neidhöfer, A. Lerner (Germany)

28 GLUTEN IMMUNOLOGICAL SIDE EFFECTS ARE DETRIMENTAL TO HUMAN HEALTH: THE JOINT ASPECTS 171

T. Matthias, A. Lerner (Israel)

29 REPORT OF 3 CASES OF UNUSUAL PATTERNS IN ANTINUCLEAR ANTIBODIES IN A REFERENCE LABORATORY 172

M.L. Lagos Yela, S.J. Echeverry-coral (Colombia)

31 EPITOPE MAPPING OF B-CELL EPITOPES ON CARBAMYLATED ALPHA 1 ANTITRYPSIN IN PATIENTS WITH RHEUMATOID ARTHRITIS 173

J. Milo, R. Albesa, M. Mahler, L. Trouw (USA)

32 EVALUATION OF TWO SPECIFIC BIOMARKERS FOR THE DIAGNOSIS OF PRIMARY BILIARY CHOLANGITIS IN A SPANISH COHORT 174

J. Milo, M. Mahler, R. Albesa, M. Garica, S. Encabo, G.L. Norman, A. Parés, S. Ruiz-Gaspà, A. Reig, C. Bentow, O. Viñas (USA)

33 ARE HIGH LEVELS OF SERUM B2 MIKROGLOBULINE, INDEPENDENT INFLAMMATORY MARKERS FROM RENAL DYSFUNCTION IN GERIATRIC POPULATION? 175

S. Ozbek, E. Bayram (Turkey)

34 COMBINED DETECTION OF IGA TO CELL-BOUND ZYMOGEN GLYCOPTOEIN 2 (GP2) ISOFORMS 1 AND 4 INCREASES THE SENSITIVITY FOR THE SEROLOGICAL DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS 176

R. Kolenda, M. Sowa, D.C. Baumgart, J. Pratschke, M. Papp, T. Tornai, J. Suchanski, D.P. Bogdanos, M.G. Mytilinaiou, M.W. Laass, K. Conrad, C. Schramm, A. Franke, D. Roggenbuck, P. Schierack (Germany)

35 LEVELS OF INFLAMMATORY SEROLOGIC BIOMARKERS IN HLA-B27 AND HLA-B15 POSITIVE PATIENTS WITH SPONDYLOARTHRITIS 177

J. Londono, A.M. Santos, J.C. Rueda, P. Peña, I. Briceño, E.L. Saldarriaga, J.I. Angarita, E. Calvo, M. Avila, N. Martinez-Rodriguez, J.F. Medina (Colombia)

53


Board number

36 VASCULITIS DAMAGE INDEX IN LIMITED AND SYSTEMIC GRANULOMATOSIS WITH POLIANGIITIS. 178

O. Vera Lastra, A. Angulo Gonzalez, G. Medina Garcia, J. Sepulveda Delgado (Mexico)

37 PREVALENCE OF SEVERE ORGANIC AFFECTION ACCORDING TO MEDSGER SCALE IN A COHORT OF MEXICAN PATIENTS WITH EARLY AND LATE SYSTEMIC SCLEROSIS. 179

O. Vera Lastra, K. Guerrero Cabrera, A. Olvera Acevedo (Mexico)

38 MULTIPLE AUTOIMMUNE SYNDROMES AND POLYAUTOIMMUNITY IN VENEZUELAN PATIENS. 180

M. Zabaleta Lanz, A. Rincones (Venezuela)

ENVIRONMENT, VACCINATION, ADJUVANTS (ASIA SYNDROME), AND AUTOIMMUNITY

39 AUTOIMMUNE/INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS (ASIA) IN DOMINICAN REPUBLIC: CASES REPORT 181

J. Then, R. Vásquez-Colón, P. Gottschalk, M. Alvarez, C. Tineo, K. Franco, E. Loyo (Dominican Republic)

40 AUTOIMMUNE-INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS. REPORT OF 5 CASES IN ARGENTINA 182

G. Mora (Argentina)

41 AUTOIMMUNE ECOLOGY IN WOMEN WITH RHEUMATIC DISEASES 183

J. Saavedra, J.E. Barahona-Correa, D. González-Bravo, M. Rojas, Y. Rodríguez, Y. Pacheco, A. Espejo-Mojica, D.M. Monsalve, M. Rodríguez-Jiménez, R.D. Mantilla, N. Molano-González, C. Ramírez-Santana, J.M. Anaya (Colombia)

42 AUTOIMMUNE/INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS (ASIA) ASSOCIATED WITH SILICONE IMPLANTS BREAST 184

O. Vera Lastra, N. Torres Oliva, P. Cruz Dominguez, G. Medrano Ramirez, L.J. Jara (Mexico)

GENETICS AND EPIGENETICS IN AUTOIMMUNITY

43 FUNCTIONAL POLYMORPHISMS IN PRE-MIR146A AND PRE-MIR499 ARE ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS BUT NOT WITH RHEUMATOID ARTHRITIS AND GRAVES’ DISEASE FROM MEXICO 185

I. Alemán Ávila, B.R. Olga, B.C. Rosa Elda, S.M. Fausto, J.M. Silvia, V.P. Guillermo, A.G. Luis Manuel, A.C. María Concepción, L.V. Ricardo, R.B. Julian (Mexico)

54


Board number

44 TNF-Α -1031T/C, -376G/A, -308 G/A AND - 238 G/A POLYMORPHISMS AND THEIR RELATIONSHIP TO SYSTEMIC LUPUS ERYTHEMATOSUS AND AUTOIMMUNE THYROIDITIS SUSCEPTIBILITY IN MEXICAN POPULATION 186

D. Cadena-Sandoval, O. Beltrán-Ramírez, R.E. Barbosa-Cobos, M.C. Aguilera-Cartas, J. Ramírez-Bello (Mexico)

45 PTPN22 1858C&GT;T POLYMORPHISM INDUCES HIGHER MEMBRANE CD154 LEVELS IN ANTI-CCP POSITIVE RHEUMATOID ARTHRITIS PATIENTS 187

J. Hernandez Bello, Y. Ruiz Noa, C.A. Palafox Sanchez, P.E. Sanchez Hernandez, M.G. Ramirez Duenas, E. Oregon Romero, M.A. Llamas Covarrubias, J.F. Munoz Valle (Mexico)

46 GENETIC CONTRIBUTION OF HLA DRB1*08:02 AND HLA DRB1*03:01 IN THE GENETIC SUSCEPTIBILITY TO DEVELOP SYSTEMIC LUPUS ERYTHEMATOSUS IN LOW SOCIOECONOMIC INCOME IN MEXICANS 188

M.T. Hernández-Martínez, M.F. García-Gutiérrez, N. Salgado, V.H. Tovar-Méndez, S. Hernández-Doño, M. Escamilla-Tilch, T.G. Perez-Suarez, M. Soler, R. Hernández-Pando, I. Baeza (Mexico)

47 ANALYSIS OF THE POLYMORPHISMS IN THE PROMOTER REGIONS OF TNF AND IL-10 IN MEXICAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. 189

M. Escamilla-Tilch, S. Hernández-Doño, T.G. Pérez-Suárez, M.F. García Gutiérrez, M.T. Hernández Martínez, V.H. Tovar-Méndez, M.N. Linares-Escobar, M. Soler, J. Granados (Mexico)

48 EFFECT OF THE MIF HAPLOTYPES ON LPS, RHTNF-Α AND RHMIF RESPONSE IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM RHEUMATOID ARTHRITIS PATIENTS AND HEALTHY SUBJECTS 190

L.A. Hernandez Palma, S. Garcia Arellano, S. Cerpa Cruz, J.F. Munoz Valle (Mexico)

49 VITAMIN D RECEPTOR GENE POLYMORPHISMS IN TURKISH PATIENTS WITH BEHCET’S DISEASE 191

G. Keskin, N.E. Dal, P. Cerci, U. Olmez (Turkey)

50 THE PTPN22 R263Q POLYMORPHISM CONFERS PROTECTION AGAINST SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS, WHILE PTPN22 R620W CONFERS SUSCEPTIBILITY TO GRAVES' DISEASE IN A MEXICAN POPULATION 192

D.J. López Cano, D. Cadena-Sandoval, O. Beltran-Ramírez, R.E. Barbosa-Cobos, F. Sánchez-Muñoz, L.M. Amezcua-Guerra, M.C. Aguilera-Cartas, J. Bautista-Olvera, G. Valencia-Pacheco, R.F. López-Villanueva, J. Ramírez-Bello (Mexico)

51 ASSOCIATION OF KIR/HLA GENOTYPES WITH SYSTEMIC SCLEROSIS IN SUBJECTS FROM SOUTHERN MEXICO 193

A.C. Machado-Sulbaran, J.E. Navarro-Zarza, M.G. Ramírez-Dueñas, J.F. Muñoz-Valle, C.J. Baños-Hernández, P.E. Sánchez-Hernández (Mexico)

52 IL-17A -121G/A AND TRAFC1-C5 RS8193037G/A POLYMORPHISMS ARE NOT ASSOCIATED WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY IN MEXICAN POPULATION 194

I. Montufar-Robles, D. López-Cano, D. Cadena-Sandoval, I. Alemán-Ávila, R.E. Barbosa Cobos, J. Ramírez Bello (Mexico)

55


Board number

53 ANALYSIS OF CATALASE GENETIC POLYMORPHISMS AND ENZYMATIC ACTIVITY IN MEXICAN VITILIGO PATIENTS 195

L.A. Ochoa-Ramírez, S.P. Díaz-Camacho, D.S. Becerra-Loaiza, V.F. Muñoz-Estrada, S.G. Cázarez-Salazar, J.J. Ríos-Tostado, J.G. Sánchez-Zazueta, J.S. Velarde-Félix (Mexico)

54 GENETIC ANALYSIS OF THE POLYMORPHISM IN THE PROMOTER REGION OF PTPN22 IN MEXICAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 196

T.G. Pérez-Suárez, S. Hernández-Doño, M.T. Hernández-Martínez, M. Escamilla-Tilch, M.F. García-Gutiérrez, M.N. Linares-Escobar, V.H. Tovar-Méndez, R. Hernández-Pando, I. Baeza, J. Granados (Mexico)

55 INFLUENCE OF IL1RN VNTR POLYMORPHISM ON IL-1RA EXPRESSION IN RHEUMATOID ARTHRITIS 197

S. Ramírez-Pérez, J. Hernández-Bello, U. De la Cruz-Mosso, E. Oregon-Romero, S. Cerpa-Cruz, M.G. Ramírez-Dueñas, J.F. Muñoz-Valle (Mexico)

56 KIR GENES AND ANTI-PADI4 LEVELS IN RHEUMATOID ARTHRITIS 198

I.V. Reyes-Pérez, P.E. Sánchez-Hernández, J.F. Muñoz-Valle, G.E. Martínez-Bonilla, S.R. Gutiérrez-Ureña, S. Cerpa-Cruz, V. González-Díaz, K.M. García-Osuna, E.E. Velarde-de la Cruz, M.G. Ramírez-Dueñas (Mexico)

57 TH1/TH2 CYTOKINES PROFILE ARE NOT UNDER INFLUENCE BY MYD88 ALLELIC VARIANTS IN RHEUMATOID ARTHRITIS BRAZILIAN PATIENTS 199

P. Sandrin-Garcia, J.E. Adelino, C.A.D.D. Lima, P.D.A.D. Santos, M.H.Q.D. Araújo, E. Rushansky, S. Crovella (Brazil)

IL17, TH17 AND AUTOIMMUNITY

59 TH1/TH17 PROFILE INDUCED BY MACROPHAGE MIGRATION INHIBITORY FACTOR IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM RHEUMATOID ARTHRITIS 200

S. García-Arellano, L.A. Hernández-Palma, R. Bucala, J. Hernández-Bello, U. De la Cruz-Mosso, T. García-Iglesias, S. Cerpa-Cruz, J.R. Padilla-Gutiérrez, Y. Valle, I. Parra-Rojas, A.L. Pereira-Suárez, J.F. Muñoz-Valle (Mexico)

60 ABD-DERIVED PROTEIN BLOCKERS OF HUMAN IL-17 RECEPTOR A AS NON-IGG ALTERNATIVES FOR MODULATION OF IL-17-DEPENDENT PRO-INFLAMMATORY AXIS 201

P. Maly, M. Hlavnickova, M. Kuchar, Z. Jiraskova-Zakostelska, H. Petrokova, L. Mareckova (Czech Republic)

61 EFFECT OF HEAT SHOCK PROTEIN 60 FROM KLEBSIELLA PNEUMONIAE ON THE EXPRESSION OF GENES ASSOCIATED WITH TH17 AND TREG CELLS, IN COLLAGEN- INDUCED ARTHRITIS 202

M.A. Rodriguez Marquez, R.H. Sanchez Trujillo, L. Jiménez Zamudio, E. García Latorre, M.L. Domínguez López (Mexico)

62 THE ROLE OF IL-6 AND IL-17 IN PATHOGENESIS OF SYSTEMIC SCLEROSIS AND EVALUATION TO ASSOCIATIONS WITH CLINICAL MANIFESTATIONS 203

T. Senturk, I. Akdam, R. Bulbul, N. Aydin (Turkey)

Board number

56


57




5tH LAtIN

AM


Poster Session 2


laca.kenes.com

59


Board number

TUESDAY, 28 NOVEMBER, 2017

CITRULLINATION AND AUTOIMMUNITY: ACPA

01 ECONOMIC IMPACT OF CCP TEST MISCLASSIFICATION (FALSE POSITIVES) IN THE DIAGNOSIS OF RHEUMATOID ARTHRITIS. A BENCHMARKING SIMULATION STUDY ACROSS SEVERAL LATIN-AMERICAN COUNTRIES. 204

C. Andalucia, G. Gallo, B. Mascialino (Sweden)

02 MONOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS DON’T HAVE AN INFLAMMATORY RESPONSE TO PLATELET DERIVED MICROPARTICLES FORMING IMMUNE COMPLEXES 205

J. Villar-Vesga, C. Grajales, C. Burbano, C.H. Muñoz, A. Vanegas-García, G. Vásquez, M. Rojas, D. Castaño (Colombia)

IMMUNOMODULATION

03 PARTHENOLIDE MODULATES IMMUNE RESPONSE IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS 206

L.B. Almeida Fontes, L.S. Aleixo de Carvalho, D.D.S. Dias, M.C. Gazolla, M.A. Juliano, G.C. Macedo, B.J. Aarestrup, F.M. Aarestrup, A.A. Da Silva Filho, J.O.A. Corrêa (Brazil)

04 IMMUNOMODULATORY EFFECTS OF LICOCHALCONE A ON EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS 207

L.B. Fontes, D.D.S. Dias, L.S.A. De Carvalho, H.L. Mesquita, B.J. Aarestrup, A.A. Da Silva Filho, J.O.A. Corrêa (Brazil)

05 REGULATION OF THE RESPONSE OF T REGULATORY LYMPOHOCYTES BY INTERFERON (IFN)-GAMMA IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS 208

G. Arellano, J. Tichauer, E. Acuña, C. Castillo, R. Naves (Chile)

06 MODIFICATION IN DISABILITY SCORES IN RHEUMATOID ARTHRITIS PATIENTS TAKING DIALYZABLE LEUKOCYTE EXTRACT 209

M. Martinez, T. Homberg, S. Pérez-Tapia, M.C. Jimenez-Martínez, P. Hernández (Mexico)

07 ANTI CD25 TREATMENT OF HUMAN DENDRITIC CELLS MODULATES THEIR CYTOKINE SYNTHESIS PROFILES AND THEIR CAPACITY TO ACTIVATE ALLOGENEIC CD4 T CELLS: A POTENTIAL TOLEROGENIC EFFECT 210

K. Mnasria, C. Lagaraine, Y. Lebranchu, R. Oueslati (Tunisia)

60

Posters - Tuesday, 28 November, 2017

Board number

08 IMMUNOMODULATORY EFFECT OF THE HEAT SHOCK PROTEIN 60 FROM YERSINIA ENTEROCOLITICA IN THE POLARIZATION OF TREG AND TH17 CELLS AND CYTOKINE PRODUCTION BY HUMAN PBMCS 211

J.P. Romero-López, J.L. Prieto-Chávez, M.L. Domínguez-López, L. Jiménez-Zamudio, L. Arriaga-Pizano, E. García-Latorre (Mexico)

09 INTERFERON GAMMA PLAYS A ROLE IN CALCIFICATION AND VIABILITY OF OSTEOBLASTS-LIKE CELLS 212

P. Sandrin-Garcia, C.A.D.D. Lima, A.P.O. Souza, M.A.B.L. Seabra, W.L. Guaraná, S. Crovella, J. De Azevedo Silva (Brazil)

10 TOLEROGENIC ACTIVITY OF IFN-Γ ON MACROPHAGES/MICROGLIA IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS 213

J. Tichauer, E. Acuña, R. Naves (Chile)

INFECTION AND AUTOIMMUNITY - MICROBIOME, INFECTOME AND INTERACTOME

11 VERNEUIL DISEASE: WHAT IS THE ROLE OF INTERNAL MEDICINE? 214

G. Bercetche-rappa, V. Torres, A. Baldomir, M. Casal (Uruguay)

12 FEVER OF UNKNOWN ORIGIN IN RHEUMATOLOGY : A PURPOSE OF THREE CASES. 215

R.A. Guzman Moreno, M.C. Mejia, V. Cadavid, L.G. Piñeros, J. Garcia, L. Pombo, K. Guzman, M.P. Ramirez, M.C. Barrera (Colombia)

13 ANTIBODIES AGAINST NEO-EPITOPE TTG COMPLEXED TO GLIADIN OUT PERFORME THE UNCOMPLEXED ANTI TTG TO FOLLOW RHEUMATIC ARTHRITIS PATIENTS 216

T. Matthias, P. Jeremias, S. Neidhöfer, A. Lerner (Germany)

14 LOW PERCENTAGES OF B-REGULATORY CELLS AND INCREASE TREGS AND CD4+IFN-Γ FREQUENCY IN PATIENTS WITH HTLV-I-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS (HAM/TSP). 217

A.V. Caicedo, Y.C. Bermúdez, C.C. Rivera, J.S. Rodriguez, G.I. Avila, J.C. Klínger, R.A. Dueñas, N. Marín, V.E. Niño (Colombia)

15 PARVOVIRUS B19 INFECTION IN MAYAN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN MEXICO. 218

G. Valencia Pacheco, Y.E. Nakazawa Ueji, E.A. Rodríguez Dzul, A.V. Angulo Ramirez, R.F. López Villanueva, I.G. Quintal Ortiz (Mexico)

61


Board number

MECHANISM AND ETIOLOGY OF AUTOIMMUNE DISEASES

16 ROLE OF MICROPARTICLES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN THE INDUCTION OF NF-ΚB DEPENDENT INFLAMMATORY MEDIATORS IN MONONUCLEAR PHAGOCYTES 219

K. Alvarez, M. Rojas, G. Vásquez (Colombia)

17 DIFFERENTIAL RESPONSE OF MONOCYTE SUBSETS TO MICROPARTICLES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS 220

L. Atehortúa, M. Rojas, G. Vásquez, C.H. Muñoz, A. Vanegas-García, D. Castaño (Colombia)

18 DETERMINATION OF CYTOKINES IN THE SYNOVIAL FLUID OF PATIENTS WITH ANKYLOSING SPONDYLITIS 221

D. Gomez Martinez, J.P. Romero Lopez, M.L. Dominguez Lopez, L. Jimenez Zamudio, J.C. Casasola Vargas, R. Burgos Vargas, A.P. Jimenez Uribe, L. Arriaga Pizano, E. Garcia Latorre (Mexico)

19 ROLE OF THYMIC B CELLS DURING THE DEVELOPMENT OF LUPUS 222

Y. Hidalgo, M.J. Fuenzalida, S. Núñez, M. Rosemblatt, D. Sauma, M.R. Bono (Chile)

20 CYSTEINYL LEUKOTRIENES LEVELS AND THEIR RECEPTORS EXPRESSION IN COLONIC MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE. 223

G. Mora, J. Alcain, A. Andrush, P. Catuogno, M. Vermeulen (Argentina)

21 THE RELATIONSHIP BETWEEN ARTERIAL STIFFNESS, VEGF AND E-SELECTIN LEVELS AND DISEASE ACTIVITY RELATION IN PATIENTS WITH RHEUMATIC DISEASES 224

T. Senturk, H. Baygin, G. Sargin, M. Yilmaz, H. Akdam (Turkey)

22 KIR2DL2/S2/L3 EXPRESSION IN NK AND T CD4+CD28NULL CELL POPULATIONS AND THEIR ASSOCIATION WITH DMARDS IN RHEUMATOID ARTHRITIS PATIENTS 225

E.E. Velarde-de la Cruz, M.G. Ramírez-Dueñas, J.F. Muñoz-Valle, P.C. Ortiz-Lazareno, G.E. Martínez-Bonilla, C.A. Palafox-Sánchez, V. González-Díaz, K.M. García-Osuna, S. Cerpa-Cruz, I.V. Reyes-Pérez, P.E. Sánchez-Hernández (Mexico)

62


Board number

NOVEL THERAPEUTIC TARGETS IN AUTOIMMUNITY

23 THERAPEUTIC TARGETING OF CD6 IN AUTOIMMUNE DISEASES: AN UPDATE ON CLINICAL TRIAL DATA WITH ITOLIZUMAB 226

P. Hernandez (Cuba)

24 NEW MARKERS FOR CELIAC DISEASE: ANTI-NEO-EPITOPE HUMAN AND MICROBIAL TRANSGLUTAMINASES 227

T. Matthias, P. Jeremias, S. Neidhöfer, A. Lerner (Germany)

25 DETERMINING THE EXPRESION OF MICRORNA-223 AS A BIOMARKER OF SEVERITY OF SYSTEMIC SCLEROSIS 228

M.A. Vargas Avila, M.D.L.A. Martínez Godínez, A. Milar García, M.D.P. Cruz Domínguez, A. Gómez Alcalá, A. Domínguez López (Mexico)

26 MESENCHYMAL STEM CELLS DECREASE OXIDATIVE STRESS IN BOWEL OF IL-10 KNOCKOUT MICE 229

I.H. Song, K.J. Jung, B.I. Jang (Daegu)

PRECISION (PERSONALIZED) MEDICINE IN AUTOIMMUNITY

27 REFRACTORY GANGRENOUS PIODERMA, REVIEW OF THE BIBLIOGRAPHY AND RECOMMENDATIONS FOR THEIR TREATMENT 230

O.E. Muñoz Monroy, M.X. Aguilar Manuel (Mexico)

28 CHRONIC PANCREATITIS AUTOINMUNE AND PSEUDOTUMOR AS A MANIFESTATION OF SYSTEMIC DISEASE RELATED TO IGG 4, PURPOSE OF TWO CLINICAL CASES 231

O.E. Muñoz Monroy, M.X. Aguilar Manuel (Mexico)

29 PERSONALIZED DIAGNOSIS AND TREATMENT FOR PATIENTS WITH RHEMATOID ARTHRITIS THROUGH GENOME-SCALE TRANSCRIPTIONAL PROFILING 232

K.J. Kim, M. Kim, I. Tagkopoulos (Republic of Korea)

PREDICTING, MONITORING AND PREVENTING

30 DIET, PARASITISM AND MICROBIOTA PROFILE IN CHILDREN WITH AUTOANTIBODIES FOR CELIAC DISEASE OR TYPE 1 DIABETES 233

S.V. Aguayo-Patrón, A.M. Calderon de la Barca (Mexico)

31 EVIDENCE OF INFLAMMATORY/FIBROTIC ACTIVITY IN THE LIVER OF ASYMPTOMATIC AND BIOCHEMICALLY NORMAL INDIVIDUALS WITH ANTI-MITOCHONDRIA ANTIBODIES: OPPORTUNITY FOR EARLY TREATMENT AND PREVENTION IN AUTOIMMUNITY 234

D. Baldo, A. Dellavance, M.L. Ferraz, L.E. Andrade (Brazil)

63


Board number

32 CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH VOGT KOYANAGI HARADA DISEASE 235

J. Losanto, A. Ojeda, S. Riquelme, Y. Yinde, L. Roman, N. Colman, M. Duarte (Paraguay)

33 OSTEOPOROSIS AND BONE METABOLISM IN SYSTEMIC SCLEROSIS 236

A. Horvath, K. Gulyas, H.P. Bhattoa, G. Szucs, Z. Szekanecz, S. Szamosi (Hungary)

PREGNANCY, SEX HORMONES AND AUTOIMMUNITY

34 PREGNANCY IN LUPUS,ANTIPHOSPHOLIPID SYNDROME AND SJOGREN SYNDROME. A 16 YEARS RETROSPECTIVE STUDY. 237

I.D. Bonilla-Gudiño, L. Andrade-Ortega, F. Irazoque-Palazuelos, S. Muñoz-Lopez (Mexico)

RITUXIMAB AND B-CELL DEPLETION THERAPY

35 RITUXIMAB FOR INTERSTITIAL LUNG DISEASE OF SYSTEMIC SCLEROSIS: A CASE SERIES OF 18 PATIENTS 238

G. Guzelant, M. Melikoglu, B. Musellim, D. Demir Yılmaz, I. Fresko, E. Seyahi, G. Hatemi, S. Ugurlu, V. Hamuryudan (Turkey)

SLE, SJÖGREN’S SYNDROME

36 CHARACTERIZATION OF COLOMBIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A SINGLE MULTICENTER EXPERIENCE 239

S. Herrera, M.A. Alzate, D. Hernandez-Parra, D. Echeverry, P. Ortiz-Salazar, R. Pineda (Colombia)

37 TITER AND IMMUNOFLUORESCENCE PATTERN OF THE ANTI-CELL ANTIBODY TEST CORRELATE WITH DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 240

M. Prado, A. Dellavance, L.E. Andrade (Brazil)

38 CYTOKINE PROFILE IN SYSTEMIC LUPUS ERYTHEMATOSUS AND POLYAUTOIMMUNITY 241

J.E. Barahona-Correa, Y. Pacheco, A. Espejo-Mojica, D.M. Monsalve, D. González-Bravo, M. Rojas, Y. Rodríguez, J. Saavedra, M. Rodríguez-Jimenez, R.D. Mantilla, N. Molano-González, C. Ramírez-Santana, J.M. Anaya (Colombia)

64


Board number

39 HYPOVITAMINOSIS D AND RELATIONSHIP WITH SLEDAI-2K IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ATTENDED IN TWO RHEUMATOLOGY SERVICES, BOGOTA 2016-2017 242

R.A. Guzman Moreno, L.G. Piñeros, J. Garcia, M.C. Mejia, V. Cadaviv, M.C. Barrera, K. Guzman Roa, J.G. Bustillo, L.M. Pombo (Colombia)

40 INCREASED EX VIVO PRODUCTION OF INTERFERON‐REGULATED CHEMOKINES IN PATIENTS WITH SJOGREN'S SYNDROME. 243

Y. Juárez-Vicuña, F. Sánchez-Muñoz, F. Sánchez, I.O. Estevez- García, L.F. Pérez, R. Bojalil, R. Márquez-Velasco, L.M. Amezcua-Guerra (Mexico)

41 SEVERITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A LATENT TRAIT ANALYSIS 244

N. Molano-Gonzalez, S.M. Juan Camilo, R.V. Adriana, R.J. Mónica, M. Rubén Dario, A. Juan-Manuel (Colombia)

42 ASSOCIATION OF ANTI-CCP ANTIBODIES AND ARTHRITIS IN PRIMARY SJOGREN’S SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS 245

N. Molano-Gonzalez, J.M. Anaya, E. Olivares-Martínez, G. Hernández-Molina (Colombia)

43 PROTECTIVE EFFECT OF ANTIMALARIALS ON THE RISK OF DAMAGE ACCRUAL IN LATIN AMERICAN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS 246

G. Pons-Estel, E. Soriano, D. Wojdyla, M. Ugarte-Gil, V. Pimentel-Quiroz, M. Scolnik, M.C. Amigo, M. Sacnun, J.A. Gómez-Puerta, G. Vásquez, M.H. Cardiel, V. Pascual-Ramos, G.S. Alarcón, E. Bonfa, L. Massardo, B. Pons-Estel (Argentina)

44 CLINICAL AND LABORATUARY FEATURES OF RHUPUS SYNDROME AND CHIARI’S NETWORK 247

T. Senturk, G. Sargın, S. Cildag (Turkey)

45 INCREASED THE RISK OF PRIMARY SJOGREN SYNDROME IN HBV-INFECTED PATIENTS 248

C.H. Tung, N.S. Lai, Y.C. Chen (Taiwan R.O.C.)

46 PREVALENCE AND CLINICAL MANIFESTATIONS OF PULMONARY AND EXTRAPULMONARY TUBERCULOSIS IN A COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 249

O. Vera Lastra, M. Cameras Orantes, J. Sepulveda Delgado, L. Pineda Galindo (Mexico)

47 PREVALENCE AND MORTALITY FROM INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN A TERTIARY LEVEL HOSPITAL 250

O. Vera Lastra, C. Camacho Guerra, J. Sepulveda Delgado, M.A. Saavedra Salinas, J.J. Terrazas, P. Cruz Dominguez, G. Medina Garcia, L.J. Jara (Mexico)

48 SECONDARY SJOGREN’S SYNDROME AND SICCA SYNDROME IN SYSTEMIC SCLEROSIS IN MEXICAN POPULATION 251

O. Vera Lastra, F. Treviño Tello, J.M. Peláez Montiel, P. Cruz Dominguez (Mexico)

49 PRETERM BIRTH IN PREGNANCIES OF WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS. 252

M. Lacerda (Brazil)

65


Board number

SOCIO-ECONOMIC DETERMINANTS OF HEALTH AND IMMUNOLOGICAL ACTIVITY

50 EVALUATION OF QUALITY OF LIFE THROUGH THE SHORT HEALTH SCALE (SHS) IN A COLOMBIAN COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE 253

S. Bernal-Macías, V. Parra-Izquierdo, F. Feris-Jassir, V. Salej-Durán, D. Sabbagh, A.M. Leguizamon-Naranjo, A.C. Hani-Amador (Colombia)

51 FAMILY AND SOCIODEMOGRAPHIC ASSOCIATION IN AUTOIMMUNE DISEASES 254

M. Herrera, J. Chavez (Guatemala)

52 RESILIENCE IN WOMEN WITH AUTOIMMUNE RHEUMATIC DISEASES 255

M. Rojas, J.E. Barahona-Correa, Y. Rodríguez, J. Saavedra, D. Gonzalez-Bravo, N. Molano-González, A. Espejo-Mojica, Y. Pacheco, D.M. Monsalve, M. Rodríguez-Jimenez, C. Ramírez-Santana, R.D. Mantilla, J.M. Anaya (Colombia)

53 PREVALENCE OF RHEUMATIC DISEASE IN AN ADULT POPULATION FROM COLOMBIA. A COPCORD METHODOLOGY STUDY. 256

A.M. Santos, J.C. Rueda, J.I. Angarita, R. Giraldo B, E. Forero, I. Pelaez-Ballestas, J.G. Ballesteros, E.L. Saldarriaga, J. Ramirez, C. Toro, J. Londono (Colombia)

THE HEART AND ATHEROSCLEROSIS AND AUTOIMMUNITY

54 COMORBIDITY IN WOMEN WITH AUTOIMMUNE RHEUMATIC DISEASES 257

D. González-Bravo, J. Saavedra, J.E. Barahona-Correa, Y. Rodríguez, M. Rojas, M. Rodríguez-Jimenez, R.D. Mantilla, N. Molano-González, J.M. Anaya (Colombia)

55 PREVALENCE OF METABOLIC SYNDROME (MS) IN PATIENTS WITH ERITEMATOSE SYSTEMIC LUPUS (SLE) EN MEXICAN POPULATION AND THE RELATION WITH INFLAMMATION MARKERS. MULTICENTER STUDY. 258

S. Muñoz López, L. Andrade Ortega, F. Irazoque Palazuelos, D. Alonso Martínez, R.A. Galaviz Perez, S. Hernandez Sandoval, M.F. Morales Irazoque (Mexico)

56 METABOLIC SYNDROME IN MEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 259

S. Muñoz López, F. Irazoque Palazuelos, L. Andrade Ortega, M.F. Moralez Irazoque (Mexico)

57 USE OF MYOCARDIAL PERFUSION AND EQUILIBRIUM RADIOISOTOPIC VENTRICULOGRAPHY IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AS A SCREENING METHOD FOR THE DETECTION OF ASYMPTOMATIC HEART DISEASE. 260

S. Hernandez Sandoval, S. Muñoz López, C.A. Peña Pérez (Mexico)

66


Board number

58 PREVALENCE OF SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DETERMINED BY CAROTID ULTRASOUND. 261

R.A. Galaviz Pérez, S. Muñoz Lopez, F. Irazoque Palazuelos, S. Hernandez Sandoval, D. Alonso Martínez (Mexico)

59 PREVALENCE OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) AT CENTRO MEDICO NACIONAL 20 DE NOVIEMBRE ISSSTE 262

B.I. Lopez Benjume, S. Muñoz Lopez, F. Irazoque Palazuelos, M.F. Morales Irazoque (Mexico)

THE IMMUNE NEURO ENDOCRINE SYSTEM AND AUTOIMMUNE DISEASES

60 CORRELATION OF METABOLIC PROFILE WITH CLINICAL PARAMETERS IN MEXICAN PATIENCES WITH MULTIPLE SCLEROSIS 263

S. Muñoz-Barrios, G. Playas-Pérez, M.O. Urióstegui-Acosta, M. Calixto-Galvez, C. González-Calixto, A. Ramírez-Peralta, I. Parra-Rojas, E. Flores-Alfaro, M.D.S. Nava-Maldonado, J.F. Muñoz-Valle (Mexico)

61 EFFECT OF TREATMENT IN MULTIPLE SCLEROSIS: ASSOCIATION WITH CLINICAL AND LABORATORY PARAMETERS 264

S. Muñoz-Barrios, G. Playas-Pérez, N.G. Salgado-Rodríguez, M.O. Urióstegui-Acosta, C. Gónzalez-Calixto, M. Calixto-Galves, A. Ramírez-Peralta, I. Parra-Rojas, J.F. Muñoz-Valle (Mexico)

62 DYSAUTONOMIA IN SJOGREN’S SYNDROME AND RHEUMATOID ARTHRITIS 265

Y. Rodríguez, J.E. Barahona-Correa, M. Rojas, A. Espejo-Mojica, P. Yovana, D.M. Monsalve, S. Juliana, M. Rodríguez-Jimenez, D. González-Bravo, N. Molano-González, R.D. Mantilla, C. Ramírez-Santana, J.M. Anaya (Colombia)

67




5tH LAtIN

AM


Index of Authors

laca.kenes.com

69


Aarestrup, B.J. 206, 207

Aarestrup, F.M. 206

Abumohor, P. 75

Acosta Ampudia, Y. 149

Acosta-Ampudia, Y. 42

Acuña, E. 208, 213

Adelino, J.E. 199

Adriana, R.V. 244

Aguayo-Patrón, S.V. 233

Aguilar Manuel, M.X. 230, 231

Aguilar-Ruiz, S.R. 104

Aguilar, J.L. 35

Aguilera-Cartas, M.C. 186, 192

Aguillón, J.C. 40, 143

Agustinelli, R. 164

Akdam, H. 224

Akdam, I. 203

Alarcon Riquelme, M. 39, 66, 68

Alarcón-Riquelme, M.E.

94, 122

Alarcón, G.S. 246

Albesa, R. 173, 174

Alcain, J. 223

Alcocer Varela, J. 92

Aleixo de Carvalho, L.S.

206

Alemán Ávila, I. 185

Alemán-Ávila, I. 194

Almeida Fontes, L.B. 206

Almendrales, L. 61

Alonso Martínez, D. 258, 261

Álvarez-Errico, D. 122

Alvarez, A. 58, 62

Alvarez, K. 219

Alvarez, M. 148, 181

Alzate, M.A. 111, 112, 239

Amezcua-Guerra, L.M.

192, 243

Amigo, M.C. 15, 115, 246

Anaya, J.M. 1, 7, 41, 42, 67, 149, 183, 241, 245, 255, 257, 265

Andalucia, C. 204

Andrade Ortega, L. 237, 258, 259

Andrade, L.E. 12, 28, 30, 164, 234, 240

Andrush, A. 223

Angarita, J.I. 45, 46, 47, 150, 151, 152, 177, 256

Angeles Garay, U. 116

Angulo Gonzalez, A. 178

Angulo Ramirez, A.V. 108, 218

Appenzeller, S. 96, 140

Araújo, M.H.Q.D. 199

Arbelaez Cortes, A. 160

Arellano, G. 208

Aroca, G. 61

Arreola, R. 168

Arriaga Pizano, L. 211, 221

Arroyo, C. 100

Atehortúa, L. 99, 220

Aure, M.A.A. 97

Ávila-Almanza, F.A. 165

Avila, G.I. 217

Avila, M. 47, 177

Aydin, N. 203

Azevedo, M.R.A. 144

Babini, A. 31

Baeza-Ramírez, I. 145

Baeza, I. 188, 196

Baldo, D. 234

Baldomir, A. 214

Ballestar, E. 122

Ballesté, R. 118

Ballesteros, J.G. 256

Baltiérrez-Hoyos, R. 51

Baños-Hernández, C.J.

193

Barahona-Correa, J.E.

41, 183, 241, 255, 257, 265

Barbosa Cobos, R.E. 194

Barbosa-Cobos, R.E. 186, 192

Barrera, M.C. 215, 242

Barturen, G. 122

Barzón, S. 159

Baumgart, D.C. 176

Bautista-Olvera, J. 192

Baygin, H. 224

Bayram, E. 175

Becerra-Loaiza, D.S. 195

Beltrán-Ramírez, O. 192, 186

Benitez, M. 48

Bentow, C. 174

Bercetche-rappa, G. 214

Beretta, L. 122

Bermúdez, Y.C. 217

Bernal-Macías, S. 165, 253

Bhattoa, H.P. 236

Bibiano-Baños, J.I. 104

Blas Hernández, P. 161

Blumenkron-Marro-quin, D.

121

Bogdanos, D.P. 176

Bojalil, R. 243

Bonfa, E. 246

Bonilla-Gudiño, I.D. 237

Bono, M.R. 222

Borghi, M.O. 44

Bradyanova, S. 49

Briceño, I. 47, 177

70

Bucala, R. 200

Bulbul, R. 203

Burbano, C. 205

Burgos Vargas, R. 221

Burgos, P. 58, 62

Bustamante, R. 100

Bustillo, J.G. 242

Buzzi, C. 118

Cadavid, A.P. 60

Cadavid, V. 215

Cadaviv, V. 242

Cadena Bonfanti, A.A. 61

Cadena-Sandoval, D. 186, 192, 194

Caicedo, A.V. 217

Cairoli, E. 24, 54, 55

Calderon de la Barca, A.M.

98, 233

Calixto-Galves, M. 264

Calixto-Gálvez, M. 263, 117

Calvo, E. 47, 177

Camacho Guerra, C. 250

Cameras Orantes, M. 249

Caputo, L.D.S. 144

Cardiel, M. 72, 73

Cardiel, M.H. 246

Carmona-Saez, P. 94

Carnero, E. 122

Carranza Muleiro, R.A.

166

Carranza-Muleiro, R.A.

113, 114

Carrasco-Torres, G. 51

Carvalho, J.L. 147

Casal, M. 214

Casasola Vargas, J.C. 221

Castaño, D. 99, 205, 220

Castillo, C. 208

Catalán, D. 40

Catalan, J. 107

Catuogno, P. 223

Cázarez-Salazar, S.G. 195

Cerci, P. 191

Ceriman, V. 157

Cerpa Cruz, S. 190

Cerpa-Cruz, S. 197, 198, 200, 225

Cervera, C. 82

Cervera, R. 16, 29, 52, 63, 64

Chacon, M. 115

Chamberlain, C. 122

Chavez, J. 254

Chelsea Bentow, C.B. 97

Chen, Y.C. 248

Chipinski, P. 49

Cildag, S. 247

Clinical Consortium / Flow Cytometry Group, P.

122

Collinot-García, G. 166

Colman, N. 235

Conklin, J. 97

Conrad, K. 176

Corrêa, J.O.A. 163, 206, 207

Corrêa, J.O.D.A. 144

Correa, N. 118

Costa-Barney, V.A. 165

Crovella, S. 199, 212

Cruz Domínguez, M.D.P.

228

Cruz Dominguez, P. 184, 250, 251

Cruz-Domínguez, M.D.P.

166

Cruz-Domínguez, M.P.

114

Culton, D. 102

Cunha dos Santos, F. 59

Cutolo, M. 105

da Silva Filho, A.A. 206, 207

Dal, N.E. 191

Danis-Lozano, R. 48

De Azevedo Silva, J. 212

de Carvalho, L.S.A. 207

de Elías, R. 159

De Jesus, G. 59

De Jesus, N. 59

De la Cruz-Mosso, U. 197, 200

Dellavance, A. 234, 240

Demir Yılmaz, D. 238

Dervieux, T. 18, 97

Deustua, L.E. 74

Dias, D.D.S. 206, 207

Díaz-Camacho, S.P. 195

Domingues, A.S. 119

Domínguez López, A. 228

Domínguez López, M.L.

211, 221, 202

Dow, E. 122

Duarte Delgado, N.P. 160

Duarte, M. 235

Dueñas, R.A. 217

Duque Botero, J. 60

Duran, A. 100

Echeverry-coral, S.J. 172

Echeverry, D. 111, 112, 239

Edwards, C. 95, 141

Encabo, S. 174

Escamilla-Tilch, M. 188, 189, 196

Espejo-Mojica, A. 41, 183, 241, 255, 265

Espinosa, G. 63

Espinoza, L.R. 78, 80

71


Estevez- García, I.O. 243

Faustinelli, V. 159

Fausto, S.M. 185

Feris-Jassir, F. 253

Fernández-Acuña, R. 117

Fernandez-Salas, I. 48

Ferraz, M.L. 234

Flores-Alfaro, E. 263

Flórez Durante, O.I. 116, 146

Fonseca-Basurto, J. 115

Fontes, L.B. 207

Forero, E. 150, 256

Franco, K. 148, 181

Franke, A. 176

Fresko, I. 238

Frostegard, J. 122

Fuenzalida, M.J. 222

Galarza-Maldonado, C.

8, 11, 57, 77

Galaviz Perez, R.A. 258, 261

Gallo, G. 204

Gandolfi, L. 119

Garay, M. 118

Garcia Arellano, S. 190

García Gutiérrez, M.F. 189

García Latorre, E. 221, 202

García-Arellano, S. 200

García-Carrasco, M. 130, 131

García-Collinot, G. 113, 114

García-González, P. 40

García-Gutiérrez, M.F. 145, 188, 196

García-Iglesias, T. 200

García-Latorre, E. 211

Garcia-Mendez, J.O. 84

García-Osuna, K.M. 198, 225

Garcia, J. 215, 242

Garica, M. 174

Gazolla, M.C. 206

Gemperline, D. 122

Gershwin, L. 133

Gershwin, M. 132

Gershwin, M.E. 129

Giraldo B, R. 256

Glumac, S. 157

Gómez Alcalá, A. 228

Gomez Martinez, D. 221

Gomez-Almaguer, D. 121

Gomez-De-Leon, A. 121

Gómez-Puerta, J.A. 32, 60, 61, 91, 246

Gomez, M. 93

González Herrera, L.J. 108

González-Bravo, D. 255, 41, 183, 241, 257, 265

González-Calixto, C. 264, 117, 263

González-Díaz, V. 198, 225

Gonzalez-Lopez, E. 121

González, L.A. 60, 61

Gonzalez, T. 93

Gottschalk, P. 148, 181

Grajales, C. 205

Granados Arriola, J. 65, 69

Granados, J. 145, 189, 196

Guaraná, W.L. 212

Guerrero Cabrera, K. 179

Guillermo, V.P. 185

Gulyas, K. 236

Gutiérrez-Ureña, S.R. 198

Guyt Rebelo, P. 59

Guzelant, G. 238

Guzman Moreno, R.A.

215, 242

Guzman Roa, K. 242

Guzmán-Guzmán, I.P. 117

Guzman, K. 215

Hamuryudan, V. 238

Hani-Amador, A.C. 165, 253

Hatemi, G. 238

Heikal, N. 50

Herbáth, M. 49

Hernandez Bello, J. 187

Hernández Martínez, M.T.

189

Hernandez Palma, L.A.

190

Hernandez Sandoval, S.

258, 260, 261

Hernández-Bello, J. 197, 200

Hernández-Doño, S. 145, 188, 189, 196

Hernandez-Lopez, D. 167

Hernández-Martínez, M.T.

145, 188, 196

Hernández-Molina, G. 245

Hernández-Osorio, L.A.

104

Hernández-Palma, L.A.

200

Hernández-Pando, R. 145, 188, 196

Hernandez-Parra, D. 111, 112, 239

Hernández, A. 60

Hernandez, M. 107

Hernández, P. 226, 209

Herrera, C. 107

Herrera, M. 168, 254

Herrera, S. 111, 112, 239

Hidalgo, Y. 222

Hirigoyen, D. 58, 62

Hlavnickova, M. 201

Homberg, T. 209

Horvath, A. 236

Ibarra, C. 97

72

Iglesias, A. 61

Irazoque Palazu-elos, F.

155, 237, 258, 259, 261, 262

Iruretagoyena, M. 58, 62

Ivanova-Todorova, E. 49

Ivantes, C.A.P. 147

Jakez-Ocampo, J. 145

Jang, B.I. 229

Jara Quezada, L.J. 2, 6, 71, 74, 166

Jara, L.J. 113, 114, 116, 146, 161, 184, 250, 100

Jarmi, V. 159

Jeremias, P. 169, 170, 216, 227

Jimenez Uribe, A.P. 221

Jiménez Zamudio, L. 221, 202

Jimenez-Arenas, D. 167

Jimenez-Martínez, M.C.

209

Jiménez-Zamudio, L. 211

Jiraskova-Zakostel-ska, Z.

201

Jovanovic, D. 157

Juan Camilo, S.M. 244

Juan-Manuel, A. 244

Juárez-Vicuña, Y. 243

Juárez, M. 122

Julian, R.B. 185

Juliana, S. 265

Juliano, M.A. 206

Jung, K.J. 229

Kampa, K.C. 147

Kane, E. 19

Kane, P. 70

Karussis, D. 27, 128

Kerick, M. 122

Keskin, G. 191

Kiener, O. 159

Kim, K.J. 232

Kim, M. 232

Klínger, J.C. 217

Kolenda, R. 176

Kontic, M. 157

Kuchar, M. 201

Kyurkchiev, D. 49

Laass, M.W. 176

Lacerda, M. 252

Lagaraine, C. 210

Lagos Yela, M.L. 172

Lai, N.S. 248

Landa-Saldívar, K. 145

Lebranchu, Y. 210

Leguizamon-Naranjo, A.M.

253

Leguizamon, A.M. 165

Lerner, A. 169, 170, 171, 216, 227

Lessa dos Anjos, T. 59

Levy, R. 59

Levy, R.A. 9, 13, 17, 142

Lima, C.A.D.D. 199, 212

Lin, C.Y. 101

Lin, J.C. 101

Lin, L. 102

Linares-Escobar, M.N. 189, 196

Llamas Covarrubias, M.A.

187

Londono, J. 45, 46, 47, 150, 151, 152, 177, 256

Lopez Benjume, B.I. 155, 262

López Cano, D.J. 192

López Villanueva, R.F. 108, 218

López-Cano, D. 194

López-Villanueva, R.F. 192

Losanto, J. 235

Loures, M.R. 147

Loyo, E. 148, 181

Luis Manuel, A.G. 185

Lujan, T.P. 160

Macedo, G.C. 206

Machado-Sulbaran, A.C.

193

Madrigal-Santillán, E.O.

113

Magalhães, C.M.R. 119

Maggi, J. 40

Mahler, M. 44, 97, 120, 173, 174

Malagón, C. 36, 93

Maly, P. 201

Malyavantham, K. 135

Mantilla, R.D. 41, 183, 241, 255, 257, 265

Manuel -Apolina, L. 166

Marcor, P. 44

Mareckova, L. 201

María Concepción, A.C.

185

Marín, N. 217

Mariz, H. 164

Markovic, J. 157

Márquez-Velasco, R. 243

Márquez, A. 118

Martin, J. 122

Martínez Godínez, M.D.L.Á.

228

Martínez-Bonilla, G.E. 198, 225

Martinez-Lavin, M. 124, 127

Martinez-Martinez, A. 167

Martinez-Martínez, L.A.

115

73


Martinez-Rodriguez, N.

47, 177

Martinez, M. 209

Martins, T. 50

Mascialino, B. 204

Massardo, L. 246

Matthias, T. 170, 171, 216, 227

Medina Garcia, G. 178, 250

Medina, G. 25, 74, 116, 146, 100

Medina, J.F. 47, 177

Medrano Ramirez, G. 184

Mehdi, A.M. 40

Mejia-Leon, M.E. 98

Mejia, M.C. 215, 242

Melikoglu, M. 238

Mendoza - Pinto, C. 79, 81

Merida, Y. 168

Meroni, P.L. 44

Mesquita, H.L. 144, 207

Mihaylova, N. 49

Milar García, Á. 228

Miller, J. 50

Milo, J. 173, 174

Mnasria, K. 210

Mohammed, T.A. 153

Molano-González, N. 41, 244, 245, 183, 241, 255, 257, 265

Molano, N. 149

Molina Aguilar, R. 116

Mónica, R.J. 244

Monsalve, D.M. 41, 42, 149, 183, 241, 255, 265

Montalva, R. 58, 62

Monteiro, S. 59

Montes-Cortes, D.H. 113, 114

Montiel Cervantes, L.A.

116

Montiel-Cervantes, L. 166

Montufar-Robles, I. 194

Mora, G. 182, 223

Morales Irazoque, M.F.

155, 258, 262

Moralez Irazoque, M.F.

259

Moranchel García, L. 154

Morsoletto, D.B.G. 147

Mosquera, A. 93

Mouthon, L. 20, 22

Muñoz López, S. 155, 261, 262, 258, 259, 260

Muñoz Monroy, O.E. 230, 231

Munoz Valle, J.F. 187, 190

Muñoz-Barrios, S. 117, 263, 264

Muñoz-Estrada, V.F. 195

Muñoz-Lopez, S. 237

Muñoz-Valle, J.F. 117, 193, 197, 198, 200, 225, 263, 264

Muñoz, C.H. 60, 61, 99, 205, 220

Murrieta, I. 121

Musellim, B. 238

Mytilinaiou, M.G. 176

Nakazawa Ueji, Y.E. 108, 218

Nava-Maldonado, M.D.S.

263

Navarro-Zarza, J.E. 193

Naves, R. 58, 62, 208, 213

Neidhöfer, S. 169, 170, 216, 227

Neira, O. 40

Nel, H.J. 40

Ney, N. 59

Nguyen, H.T. 107

Niño, V.E. 217

Nóbrega, Y.K.M. 119

Nones, R.B. 147

Norman, G.L. 174

Núñez, S. 222

O’Malley, T. 97

Ochoa-Ramírez, L.A. 195

Ojeda, A. 235

Olga, B.R. 185

Olivares-Gazca, J.C. 121

Olivares-Martínez, E. 245

Olmez, U. 191

Olvera Acevedo, A. 179

Oregon Romero, E. 187, 197

Ortiz Reyes, B.L. 61, 160

Ortiz-Lazareno, P.C. 225

Ortiz-Salazar, P. 111, 112, 239

Oueslati, R. 210

ozbek, S. 175

Pacheco, Y. 41, 42, 183, 241, 255

Padilla-Gutiérrez, J.R. 200

Palafox Sanchez, C.A. 187, 225

Papp, M. 176

Parés, A. 174

Parra-Izquierdo, V. 165, 253

Parra-Rojas, I. 200, 263, 264

Pascual-Ramos, V. 246

Pavía, P.X. 150

Pedroso, M.L.A. 147

Peláez Montiel, J.M. 251

Pelaez-Ballestas, I. 45, 46, 150, 151, 152, 256

Peña Pérez, C.A. 260

74

Peña, P. 47, 177

Pereira Junior, O.D.S. 163

Pereira-Suárez, A.L. 200

Perez Mendoza, G. 108

Pérez-Suárez, T.G. 188, 189, 196

Pérez-Tapia, S. 209

Pérez, L.F. 243

Pers, J.O. 122

Petrokova, H. 201

Pimentel-Quiroz, V. 246

Pineda Galindo, L. 249

Pineda Galindo, L.F. 154

Pineda, R. 111, 112, 239

Piñeros, L.G. 215, 242

Pinzon, C. 150

Pissaia Junior, A. 147

Playas-Pérez, G. 117, 263, 264

Pombo, L. 215

Pombo, L.M. 242

Pons-Estel, B. 246

Pons-Estel, G. 38, 63, 87, 89, 246

Posada-Duque, R.A. 99

Prado, M. 164, 240

Prager, K. 170

Pratesi, R. 119

Pratschke, J. 176

Prechl, J. 49

Prieto-Chávez, J.L. 211

Putterman, C. 110, 137, 139

Qian, Y. 102

Quintal Ortiz, I.G. 218

Quintana, R. 63

Quirantes, R. 122

Radojevic Skodric, S. 157

Rahamani, M.A.B. 156

Ramamoorthy, R. 103

Ramírez Bello, J. 194

Ramirez Duenas, M.G.

187

Ramirez Santana, C. 4, 43, 149

Ramírez-Bello, J. 186, 192

Ramírez-Dueñas, M.G.

193, 197, 198, 225

Ramírez-Peralta, A. 117, 263, 264

Ramírez-Pérez, S. 197

Ramírez-Santana, C. 76, 41, 42, 183, 241, 255, 265

Ramirez, J. 256

Ramirez, M.P. 215

Rao, S. 122

Reig, A. 174

Renaudineau, Y. 122

Reséndiz Albor, A.A. 166

Restrepo Escobar, M. 160

Reyes Maldonado, E. 116

Reyes-Pérez, I.V. 198, 225

Ricardo, L.V. 185

Rincones, A. 180

Ríos-Tostado, J.J. 195

Riquelme, S. 235

Rivera-Bravo, B. 167

Rivera, C.C. 217

Rivero Cardenas, N.A. 108

Rodrigues, B. 106

Rodrigues, S. 164

Rodríguez Dzul, E.A. 218

Rodriguez Iturbe, B. 26, 109

Rodriguez Marquez, M.A.

202

Rodriguez Sisniega, N.

118

Rodriguez Velandia, Y.A.

149

Rodríguez-Jiménez, M.

41, 241, 255, 257, 265, 183

Rodriguez, A. 100

Rodriguez, J.S. 217

Rodríguez, Y. 41, 42, 183, 241, 255, 257, 265

Roggenbuck, D. 44, 176

Rojas, M. 41, 99, 183, 205, 219, 220, 241, 255, 257, 265

Roksandic Milenkovic, M.

157

Roman, L. 235

Romero Lopez, J.P. 221

Romero-López, J.P. 211

Romero-Tlalolini, M.D.L.A.

51

Rosa Elda, B.C. 185

Rosemblatt, M. 222

Rua, C. 60

Rubén Dario, M. 244

Rueda, J.C. 45, 46, 47, 150, 151, 152, 177, 256

Rueda, J.M. 150

Ruiz Noa, Y. 187

Ruiz-Arguelles, A. 121

Ruiz-Arguelles, G. 121

Ruiz-Delgado, G. 121

Ruiz-Gaspà, S. 174

Ruiz, S. 60

Rushansky, E. 199

Saaibi, D.L. 150

Saavedra Salinas, M.A.

146, 250

75


Saavedra, J. 41, 183, 241, 255, 257

Saavedra, M.A. 114, 100

Sabbagh, D. 253

Sacnun, M. 246

Salazar-Uribe, J.C. 111, 112

Saldarriaga, E.L. 45, 46, 47, 150, 151, 152, 177, 256

Salej-Durán, V. 253

Salgado-Molina, Y.G. 117

Salgado-Rodríguez, N.G.

264

Salgado, N. 188

Salinas, S.M. 35

Sanchez Hernandez, P.E.

187

Sanchez Trujillo, R.H. 202

Sánchez-Barbosa, S. 145

Sánchez-Hernández, P.E.

193, 198, 225

Sánchez-Muñoz, F. 192, 243

Sánchez-Rodríguez, A.

161

Sánchez-Zazueta, J.G.

195

Sanchez, A. 100

Sánchez, F. 243

Sandrin-Garcia, P. 199, 212

Santos, A.M. 45, 46, 47, 150, 151, 152, 177, 256

Santos, P.D.A.D. 199

Sargin, G. 224

Sargın, G. 247

Sauma, D. 222

Scheinberg, M. 10, 37, 136, 138

Schierack, P. 44, 176

Schinnerling, K. 40

Schramm, C. 176

Scolnik, M. 246

Seabra, M.A.B.L. 212

Segura, A. 122

Selleski, N. 119

Senturk, T. 203, 224, 247

Sepulveda Delgado, J.

48, 178, 249, 250

Sepúlveda, A. 40

Serrano Morales, R.M.

63

Seyahi, E. 238

shankerlingam, D.R. 103

Sherer, Y. 14

Shoenfeld, Y. 3, 105, 125

Sigala-Robles, R. 98

Silvia, J.M. 185

Skodric Trifunovic, V. 157

Soler, M. 188, 189

Solis-martinez, R. 158

Song, I.H. 229

Soriano, E. 246

Soriano, E.R. 21, 23, 90

Sosa-Luis, S.A. 104

Soto-Lopez, M.E. 167

Soto, L. 40

Souza, A.P.O. 212

Sowa, M. 176

Suchanski, J. 176

Sulli, A. 105

Szamosi, S. 236

Szekanecz, Z. 236

Szucs, G. 236

Tagkopoulos, I. 232

Tchorbanov, A. 49

Tebo, A.E. 50

Teotônio, I.M.S.N. 119

Terrazas, J.J. 250

Then, J. 148, 181

Thomas, R. 40

Tichauer, J. 208, 213

Tineo, C. 148, 181

Tornai, T. 176

Toro Dominquez, D. 94

Toro, C. 256

Torres Oliva, N. 184

Torres-aguilar, H. 104

Torres-Ruiz, J. 105

Torres, V. 214

Torsten, M. 169

Tovar-Méndez, V.H. 145, 188, 189, 196

Treviño Tello, F. 251

Trouw, L. 173

Tung, C.H. 248

Uenishi, R.H. 119

Ugarte-Gil, M. 53, 56, 86, 88, 246

Ugurlu, S. 238

Urióstegui-Acosta, M.O.

117, 263, 264

Urrego, T. 60, 61

Valencia Pacheco, G. 108, 192, 218

Valle, Y. 200

Vanegas-García, A. 60, 99, 205, 220

Vanegas-García, A.L. 61

Vanelli, C.P. 144, 163

Vargas Avila, M.A. 228

Vargas CA 93

Vargas-Arzola, J. 104

Vasconcelos, C. 85

Vásquez-Colón, R. 148, 181

Vásquez-Garzón, V.R. 51

76

Vásquez, G. 160, 60, 61, 99, 205, 219, 220, 246

Vazquez del Mercado, M.

33, 134

Vázquez-Cóbix, Y. 51

Vázquez-Villamar, M. 117

Velarde-de la Cruz, E.E.

198, 225

Velarde-Félix, J.S. 195

Velásquez, M. 60

Vengudusamy, S. 103

Vera Lastra, O. 5, 83, 123, 126, 161, 178, 179, 184, 249, 250, 251

Vera Lastra, O.L. 48, 113, 114, 154

Verdugo, R.A. 40

Vermeulen, M. 223

Vilela, V. 59

Vilela, V.S. 34

Villa-Treviño, S. 51

Villar-Vesga, J. 205

Viñas, O. 174

Vucinic Mihailovic, V. 157

Vukanic, I. 157

Wojcik, J. 122

Wojdyla, D. 246

Wong-Baeza, C. 145

Wu, C.S. 101

Yepez, R. 93

Yilmaz, M. 224

Yilmaz, Z. 162

Yinde, Y. 235

Yovana, P. 265

Zabaleta Lanz, M. 180

Zlotnik, A. 107

Zurita, E. 74, 100

77


Notes

78

Notes

79


80

Notes

laca 2017 final programlaca2017.kenes.com/documents/laca 2017 final program.pdf · 5th latin...

Documents